{
  "meta": {
    "title": "00023_Late_Night_Pyq_Pyt_Marathon_-_23",
    "url": "https://brainandscalpel.vercel.app/00023-late-night-pyq-pyt-marathon-23-1a39f322.html",
    "scrapedAt": "2025-11-29T17:24:36.509Z"
  },
  "questions": [
    {
      "id": 20251,
      "choices": [
        {
          "id": 80965,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
        },
        {
          "id": 80966,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Regurgitation</span></p>"
        },
        {
          "id": 80967,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
        },
        {
          "id": 80968,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Among the given options, murmur given in the image is associated with? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/whatsapp-image-2023-06-12-at-1901276.jpg\" alt=\"\" width=\"400\" height=\"70\"></span></p>",
      "unique_key": "Q7877972",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Mitral Regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided indicates a murmur occurring between S1 and S2, which is described as <strong>a pan-systolic murmur</strong>. This type of murmur spans the entirety of systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mitral Regurgitation</strong> produces a pan-systolic murmur due to the backward flow of blood from the left ventricle into the left atrium throughout systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic Regurgitation:</strong> Characterized by an <strong>early diastolic murmur</strong> due to backflow of blood from the aorta into the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Stenosis:</strong> Characterized by a <strong>mid-diastolic murmur</strong> due to obstructed blood flow from the left atrium to the left ventricle during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aortic Stenosis:</strong> Characterized by an <strong>ejection systolic murmur</strong> due to turbulent blood flow across a narrowed aortic valve during systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitral regurgitation is associated with a pan-systolic murmur, which is present throughout the systole and heard between the S1 and S2 heart sounds.</span></p>",
      "correct_choice_id": 80966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54258,
      "choices": [
        {
          "id": 216501,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsus Paradoxus is usually seen</span></p>"
        },
        {
          "id": 216502,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardiocentesis may be required</span></p>"
        },
        {
          "id": 216503,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1 is a common finding</span></p>"
        },
        {
          "id": 216504,
          "text": "<p><span style=\"font-size:12.0pt;\">Echo will show diastolic RA/RV collapse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of chest pain and upper respiratory tract infection, seven days ago, presents with shortness of breath. She has BP of 100/60 mm Hg and a pulse rate of 110/min. Chest x-ray reviews an enlarged heart, which appears like a water bottle. Which of the following is incorrect?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5137273",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Loud S1 is a common finding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is likely suffering from <strong>pericardial effusion</strong>, possibly progressing to cardiac tamponade, secondary to a recent viral infection. This is suggested by the history of an upper respiratory tract infection, the physical findings, and the characteristic \"water bottle\" appearance of the heart on the chest x-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incorrect statement is <strong>Loud S1 is a common finding</strong>. In fact, one of the hallmarks of cardiac tamponade is <strong>muffled or distant heart sounds</strong> due to the insulating effect of the pericardial fluid, as described in Beck's triad, which includes hypotension, jugular venous distension, and muffled heart sounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulsus Paradoxus is usually seen:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pulsus paradoxus is a significant drop in blood pressure during inspiration, common in cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pericardiocentesis may be required:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pericardiocentesis is often necessary to remove the excess fluid and relieve pressure on the heart, especially if the patient is hemodynamically unstable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Echo will show diastolic RA/RV collapse:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. In cardiac tamponade, the pressure from the pericardial fluid prevents the right atrium and right ventricle from expanding during diastole, leading to their collapse.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Echocardiography will reveal this diastolic collapse, confirming cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, muffled heart sounds are a key finding, not a loud S1.</span></p>",
      "correct_choice_id": 216503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11402,
      "choices": [
        {
          "id": 45574,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hypersecreting adenoma</span></p>"
        },
        {
          "id": 45575,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
        },
        {
          "id": 45576,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Grave’s disease</span></p>"
        },
        {
          "id": 45577,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Lateral aberrant thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below is a radioactive scan for thyroid pathology. which of the following is the most probable diagnosis: (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm56.jpg\" alt=\"\" width=\"300\" height=\"256\"></span></p>",
      "unique_key": "Q3881893",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypersecreting Adenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image findings are suggestive of hypersecreting adenoma.</span></p><p>&nbsp;</p><ol><li><span style=\"color:black;font-size:12.0pt;\">Increased uptake in the right lobe at the thyroid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Suppressed uptake in left lobe of thyroid</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings are highly suggestive of a hypersecreting adenoma. This condition occurs when a benign tumor in the thyroid gland produces thyroid hormone independently of the normal regulatory mechanisms, leading to an overactive area (hot spot) in one part of the thyroid, with suppression of activity in the rest of the gland due to negative feedback mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papillary carcinoma of the thyroid:</strong> Incorrect as this type of cancer typically presents with a \"cold nodule,\" which shows reduced or no uptake on a radioactive scan. The scan shows no areas of reduced uptake indicative of a cold nodule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grave’s disease:</strong> Incorrect because Grave's disease generally causes a diffuse increase in uptake across the entire thyroid gland due to widespread stimulation of thyroid tissue. The scan does not show diffuse uptake, which rules out Grave's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral aberrant thyroid:</strong> Incorrect as this condition involves ectopic thyroid tissue that might appear as functioning thyroid tissue outside the normal location. The scan does not indicate any ectopic thyroid tissue.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypersecreting adenoma in the thyroid is characterized by increased radioactive uptake in one area of the thyroid with suppression in other areas, reflecting independent hormone production from the adenoma.</span></p>",
      "correct_choice_id": 45574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11348,
      "choices": [
        {
          "id": 45358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD4+ T cell count</span></span></span></p>"
        },
        {
          "id": 45359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load</span></span></span></p>"
        },
        {
          "id": 45360,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p24 antigen</span></span></span></p>"
        },
        {
          "id": 45361,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral serotype</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q8938833",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439574,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Viral load</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the primary method used to monitor the efficacy of antiretroviral therapy (ART) in patients with HIV. According to WHO and NACO guidelines, the monitoring of viral load is crucial for assessing the effectiveness of the treatment. Initially, viral load is <strong>monitored every six months until the regimen is stabilized</strong>. <strong>After that, it is monitored annually.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The goal of ART is to achieve an undetectable viral load, defined as <strong>less than 50 copies per mL</strong>. If the viral load is less than 50 copies, it indicates effective suppression of the virus, and the patient can continue with the same ART regimen with yearly monitoring. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">If the viral load exceeds 1000 copies, it suggests treatment failure</span></strong><span style=\"font-size:12.0pt\">, necessitating a change in the ART regimen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">For viral loads between 50 and 1000 copies, the issue is often due to poor adherence to therapy,&nbsp;</span></strong><span style=\"font-size:12.0pt\">and it is recommended to ensure adherence and frequently <strong>monitor viral load every three months</strong> until suppression is achieved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>CD4+ T cell count</strong>: Previously, CD4+ T cell count was commonly used to monitor HIV treatment. However, current guidelines prioritize viral load over CD4 count for monitoring treatment efficacy. While CD4 count is still important for assessing the immune system&#39;s health, it is not the primary marker for treatment efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>p24 antigen</strong>: The p24 antigen is a protein associated with HIV. It is used for early detection of HIV infection but is not suitable for monitoring long-term treatment efficacy. p24 levels do not provide reliable information on viral suppression or ART effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Viral serotype</strong>: Viral serotyping involves identifying different strains of HIV but does not provide information on treatment efficacy. It is more relevant in epidemiological studies and vaccine development rather than in monitoring ongoing therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the most important and recommended method for monitoring the efficacy of antiretroviral therapy in HIV patients. The goal is to achieve an undetectable viral load (&lt;50 copies/mL).</span></span></span></p>",
      "correct_choice_id": 45359,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24764,
      "choices": [
        {
          "id": 99017,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr; 1 &rarr; 2</span></span></p>"
        },
        {
          "id": 99018,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr; 2 &rarr; 1</span></span></p>"
        },
        {
          "id": 99019,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 &rarr; 1 &rarr; 3</span></span></p>"
        },
        {
          "id": 99020,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &rarr; 2 &rarr; 3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Order in which the following heart sounds are heard from superior to inferior on the left side chest wall? </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.Pulmonary area</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2.Erb&rsquo;s area</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3.Mitral area</span></span></span></p>",
      "unique_key": "Q9702202",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439575,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 1 &rarr; 2 &rarr; 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The heart sounds are heard in the following order from superior to inferior on the left side chest wall: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary area: 2nd intercostal space near the sternum </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erb&rsquo;s area (2<sup>nd</sup> aortic area): 3rd intercostal space near the sternum </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Mitral area: 4th intercostal space at the midclavicular line (away from sternum).</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct order from superior to inferior for heart sounds on the left side chest wall is pulmonary area, Erb&rsquo;s area, and mitral area.</span></span></span></p>",
      "correct_choice_id": 99020,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11434,
      "choices": [
        {
          "id": 45702,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthenospermia</span></p>"
        },
        {
          "id": 45703,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligospermia</span></p>"
        },
        {
          "id": 45704,
          "text": "<p><span style=\"font-size:12.0pt;\">Epididymis obstruction</span></p>"
        },
        {
          "id": 45705,
          "text": "<p><span style=\"font-size:12.0pt;\">Undescended testes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is due to which of the following? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q5486806",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439576,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asthenospermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Asthenospermia (Immotile sperm [Greek sthenos = strength]</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener result from&nbsp;<strong>loss of function of axonemal dynein that impairs sperm motility</strong>. Respiratory Ciliary dysmotility leads to bronchiectasis and recurrent infections. Association of situs inversus is noted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oligospermia:&nbsp;</strong>Incorrect because while sperm count can be affected in some genetic or hormonal disorders, in Kartagener's syndrome, the sperm count is typically normal; the issue lies in their motility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Epididymis obstruction:&nbsp;</strong>Incorrect as this is not a feature of Kartagener’s syndrome. While structural anomalies in the reproductive tract can lead to such issues, Kartagener’s syndrome specifically affects the motility of sperm due to ciliary dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Undescended testes:&nbsp;</strong>Incorrect as undescended testes are not associated with Kartagener’s syndrome, which primarily affects ciliary function and not the anatomical position of the testes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infertility in Kartagener's syndrome is primarily due to asthenospermia, which is caused by the immobility of sperm. This immotility results from the genetic defect affecting the dynein arm of sperm flagella, similar to the defect affecting cilia in the respiratory tract, leading to the classic symptoms of the syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Pulmonology/Bronchiectasis/Chapter 290</strong></span></p>",
      "correct_choice_id": 45702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50950,
      "choices": [
        {
          "id": 203341,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3&nbsp;</span></p>"
        },
        {
          "id": 203342,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 5&nbsp;</span></p>"
        },
        {
          "id": 203343,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5&nbsp;</span></p>"
        },
        {
          "id": 203344,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man presented with an acute onset of chest pain radiating to the left arm and diaphoresis. His ECG and cardiac biomarkers show non-ST elevation myocardial infarction. Which of the following will be used in the treatment of this patient? (</span>INICET Nov 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Atorvastatin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">2. Aspirin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">3. Clopidogrel&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">4. Low molecular weight heparin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">5. Alteplase</span></p>",
      "unique_key": "Q9418706",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439577,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of non-ST elevation myocardial infarction (NSTEMI), several medications are routinely used to reduce the risk of further ischemic events and manage the condition effectively:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Atorvastatin: High-intensity statin therapy is recommended to lower cholesterol levels and stabilize atherosclerotic plaques.</span></li><li><span style=\"font-size:12.0pt;\">Aspirin: This antiplatelet agent is essential for reducing clot formation and preventing further arterial blockage.</span></li><li><span style=\"font-size:12.0pt;\">Clopidogrel: Another antiplatelet agent, often used in combination with aspirin, to provide dual antiplatelet therapy (DAPT), which is beneficial in preventing further ischemic events.</span></li><li><span style=\"font-size:12.0pt;\">Low molecular weight heparin: Anticoagulant therapy, such as enoxaparin, is crucial in preventing thrombus formation and managing NSTEMI. Enoxaparin is typically administered subcutaneously at a dose of 1 mg/kg twice daily.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. Alteplase: This thrombolytic agent is used in the management of ST-elevation myocardial infarction (STEMI) when percutaneous coronary intervention (PCI) is not immediately available. It is not indicated for NSTEMI due to the lack of ST elevation and the associated risks of bleeding without significant benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For NSTEMI management, the treatment includes Atorvastatin, Aspirin, Clopidogrel, and Low molecular weight heparin. Thrombolytic agents like Alteplase are reserved for STEMI with specific indications.</span></p>",
      "correct_choice_id": 203344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11497,
      "choices": [
        {
          "id": 45954,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral malaria</span></p>"
        },
        {
          "id": 45955,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptospirosis</span></p>"
        },
        {
          "id": 45956,
          "text": "<p><span style=\"font-size:12.0pt;\">Brucellosis</span></p>"
        },
        {
          "id": 45957,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following is a graphic representation of a patient admitted in medicine ward with fever. What could be the possible diagnosis? (AIIMS MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture33.jpg\" alt=\"\" width=\"300\" height=\"179\"></span></p>",
      "unique_key": "Q2289665",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Leptospirosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image shows typical&nbsp;<strong>biphasic illness with initial leptospiremic</strong> <strong>phase&nbsp;</strong>followed by immune phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other illness that shows biphasic pattern include measles, Tick borne encephalitis virus, rarely Zika virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>Modified Faine Criteria </strong></i><strong>is used for diagnosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture34.jpg\" alt=\"\" width=\"600\" height=\"386\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Monophasic illness with predominant CNS and multisystem involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. Undulant fever presenting with PUO, muscle pain, thoracic backpain</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. Enteric fever causes step ladder pattern of fever.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leptospirosis should be considered in patients presenting with a biphasic fever pattern, especially when supported by epidemiologic data pointing to possible exposure to contaminated water or animals. Early diagnosis and treatment are crucial to prevent complications such as Weil's disease, which can lead to severe renal and hepatic issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Leptospirosis/Chap 184</strong></span></p>",
      "correct_choice_id": 45955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57274,
      "choices": [
        {
          "id": 228477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 228478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        },
        {
          "id": 228479,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
        },
        {
          "id": 228480,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 48-year-old woman with no significant past medical history presents to the emergency department with a complaint of severe headaches. Physical examination reveals a slightly elevated blood pressure of 150/90 mm Hg, and the neurological exam shows no focal deficits, but the patient appears visibly distressed and in pain. Which of the following types of headaches requires further evaluation?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Headache lasting more than a few hours without relief</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Sudden onset severe headache described as the &quot;worst headache of life&quot;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">New-onset headache that is progressively worsening</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Headache associated with visual symptoms, such as blurred vision</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2225725",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439579,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. 2, 3, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option 2: Sudden onset severe headache described as the &quot;worst headache of life&quot;</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">This description is a classic red flag for a subarachnoid hemorrhage, particularly when the headache occurs suddenly and with severe intensity. Such a presentation requires immediate evaluation with neuroimaging, typically a CT scan, to rule out a potentially life-threatening condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option 3: New-onset headache that is progressively worsening</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A new, progressively worsening headache, particularly in a patient without a prior history of similar headaches, suggests a serious underlying condition such as a brain tumor, increased intracranial pressure, or another significant pathology. This warrants further evaluation with neuroimaging to determine the cause.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option 4: Headache associated with visual symptoms, such as blurred vision</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Headaches with associated visual symptoms raise concern for conditions like increased intracranial pressure, optic neuritis, or other neurological disorders. Blurred vision with headache necessitates prompt evaluation to exclude serious conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option 1: Headache lasting more than a few hours without relief</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">While prolonged headaches can be distressing, they often occur in benign conditions such as migraines or tension-type headaches. The duration alone does not necessitate urgent evaluation unless it is accompanied by other red flag symptoms, such as neurological changes or sudden onset.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Headaches that present as the worst headache of one&rsquo;s life, are new and progressively worsening, or are associated with visual disturbances require urgent medical evaluation. These red flags suggest potential serious conditions like subarachnoid hemorrhage, brain tumors, or increased intracranial pressure, necessitating prompt investigation and management to prevent complications.</span></span></span></p>",
      "correct_choice_id": 228479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11242,
      "choices": [
        {
          "id": 44934,
          "text": "<p><span style=\"font-size:12.0pt;\">Encephalopathy attributed to HIV</span></p>"
        },
        {
          "id": 44935,
          "text": "<p><span style=\"font-size:12.0pt;\">Invasive cervical cancer</span></p>"
        },
        {
          "id": 44936,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis of any site</span></p>"
        },
        {
          "id": 44937,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral candidiasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are AIDS defining illnesses except: (NEET PG 2019)</span></p>",
      "unique_key": "Q4046047",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439620,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Oral Candidiasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Oral candidiasis, while commonly associated with HIV infection, is not itself an AIDS-defining illness. The Centers for Disease Control and Prevention (CDC) list of AIDS-defining illnesses includes more severe manifestations such as candidiasis of the esophagus, trachea, bronchi, or lungs, but not oral candidiasis. This fungal infection is often seen in patients with HIV as a marker of immune suppression but does not qualify as an indicator of AIDS on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Encephalopathy attributed to HIV:</strong> This is an AIDS-defining condition, as it represents a direct effect of HIV on the brain resulting in cognitive impairment and motor dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Invasive cervical cancer:</strong> This is considered an AIDS-defining illness due to the high risk and prevalence of this cancer in individuals with advanced HIV, reflecting a significant degree of immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycobacterium tuberculosis of any site:</strong> Tuberculosis, whether pulmonary or extrapulmonary, is an AIDS-defining illness due to its severity and frequency in the context of HIV-induced immune suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110710.jpg\" alt=\"\" width=\"1000\" height=\"359\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Infectious Disease/Chap 202</strong></span></p>",
      "correct_choice_id": 44937,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11584,
      "choices": [
        {
          "id": 46302,
          "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
        },
        {
          "id": 46303,
          "text": "<p><span style=\"font-size:12.0pt;\">Alprazolam</span></p>"
        },
        {
          "id": 46304,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonazepam</span></p>"
        },
        {
          "id": 46305,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old chronic alcoholic presented with withdrawal symptoms. His liver function tests showed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AST 140 IU/L,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALT 110 IU/L, and</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GGT 500 IU/L.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following benzodiazepines can be safely administered to this patient? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q8331787",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439621,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's liver function tests indicate elevated liver enzymes (AST, ALT, and GGT), suggesting potential alcoholic hepatitis or liver impairment. In such cases, choosing the appropriate benzodiazepine is crucial due to the liver's role in drug metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a preferred benzodiazepine in patients with liver impairment for the following reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Short-acting</strong>: Lorazepam is a short-acting benzodiazepine, which means it has a shorter half-life and less risk of accumulation in the body compared to long-acting benzodiazepines.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Minimal liver metabolism</strong>: Lorazepam undergoes minimal hepatic metabolism, which makes it safer for patients with impaired liver function. This reduces the risk of adverse effects and toxicity.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Diazepam:</strong> Diazepam is a long-acting benzodiazepine. It undergoes extensive hepatic metabolism, leading to active metabolites that can accumulate, especially in patients with liver dysfunction. This increases the risk of prolonged sedation and toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Alprazolam:</strong> Alprazolam, although shorter-acting than diazepam, still undergoes significant liver metabolism. It is not as safe as lorazepam in patients with compromised liver function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clonazepam</strong>: Clonazepam is also a long-acting benzodiazepine with extensive hepatic metabolism. Like diazepam, its use in patients with liver impairment can lead to accumulation and increased risk of side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with liver impairment, such as those with alcoholic hepatitis, lorazepam is the preferred benzodiazepine due to its short-acting nature and minimal hepatic metabolism.</span></p>",
      "correct_choice_id": 46305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11699,
      "choices": [
        {
          "id": 46762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin </span></span></span></span></p>"
        },
        {
          "id": 46763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone </span></span></span></span></p>"
        },
        {
          "id": 46764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin</span></span></span></span></p>"
        },
        {
          "id": 46765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liraglutide</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A morbidly obese diabetic woman is not responsive to metformin therapy. She has a history of pancreatitis and family history of bladder cancer. She does not want to take injections. Which of the following would be suitable to reduce her glucose levels? (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q3460480",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439622,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Canagliflozin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin is a suitable oral medication for a diabetic patient not responding to metformin, especially when she has a history of pancreatitis and a family history of bladder cancer, and prefers to avoid injectable medications. Canagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which helps the kidneys excrete glucose through urine, thus lowering blood glucose levels</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sitagliptin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not ideal as it has been associated with a risk of acute pancreatitis, which poses a significant risk given her medical history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pioglitazone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should be avoided due to its potential link with bladder cancer, especially considering her family history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Liraglutide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although effective in managing diabetes, it is not suitable as it is an injectable medication and the patient prefers to avoid injections. Moreover, it also carries a risk of pancreatitis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In choosing diabetes medications for patients with specific health concerns, it&#39;s crucial to consider both the efficacy and the side-effect profile of the drug, as well as patient preferences for administration methods to ensure compliance and safety. Canagliflozin is an appropriate choice for this patient due to its oral administration and lower risk concerning her medical history.</span></span></span></span></p>",
      "correct_choice_id": 46764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11872,
      "choices": [
        {
          "id": 47454,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Putamen</span></span></p>"
        },
        {
          "id": 47455,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subthalamic nucleus</span></span></p>"
        },
        {
          "id": 47456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caudate nucleus</span></span></p>"
        },
        {
          "id": 47457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globus pallidus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presented with violent, flinging movements. Where is the lesion causing the hemiballismus seen? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q3909935",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439623,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subthalamic nucleus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus is characterized by involuntary, violent, flinging movements, typically on one side of the body. This condition is most commonly associated with a lesion in the subthalamic nucleus. The subthalamic nucleus plays a crucial role in regulating movements, and damage to this area can lead to the excessive, uncontrolled movements seen in hemiballismus. This differentiates it from lesions in other parts of the basal ganglia, which are associated with different movement disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Putamen:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the putamen are more commonly associated with chorea, which involves rapid, involuntary, and irregular movements, rather than the violent flinging movements of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caudate nucleus:</span></strong><span style=\"font-size:12.0pt\"> Similar to the putamen, lesions in the caudate nucleus typically result in chorea. The caudate nucleus is part of the striatum, and its dysfunction does not usually present with the violent movements characteristic of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Globus pallidus:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the globus pallidus often result in athetosis, which involves slow, writhing movements. This is different from the abrupt and forceful movements seen in hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus, characterized by violent, flinging movements, is most commonly caused by a lesion in the subthalamic nucleus.</span></span></span></p>",
      "correct_choice_id": 47455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11308,
      "choices": [
        {
          "id": 45198,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add long-acting nitrate</span></span></p>"
        },
        {
          "id": 45199,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase metoprolol dose to 100mg BID</span></span></p>"
        },
        {
          "id": 45200,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add clopidogrel 75mg OD</span></span></p>"
        },
        {
          "id": 45201,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start enoxaparin 1mg/kg s.c BD</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 53-year-old gentleman presents with chest pain which is happening at rest. Pain is persistent for 3-5 minutes and he is having recurrent pain over the last 48 hours and he used 3 puffs of GTN to relieve his pain. His current medications include GTN PRN, Atorvastatin 20mg HS, Metoprolol 50mg BID, and Aspirin 75mg OD. His troponin was negative and ECG showed LVH with flattening of the ST segment. What is the most appropriate next step in management?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q6273281",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439624,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Start enoxaparin 1mg/kg s.c BD</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is presenting with symptoms suggestive of unstable angina, given the recurrent chest pain at rest and ECG changes (left ventricular hypertrophy with ST segment flattening). Despite the negative troponin, which rules out myocardial infarction, the clinical scenario points to a high risk of acute coronary syndrome (ACS).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For high-risk ACS, especially in a patient already on medications for coronary artery disease (CAD) like aspirin, atorvastatin, and metoprolol, initiating anticoagulation therapy is crucial to prevent thrombus formation and progression to myocardial infarction. <strong>Enoxaparin</strong>, a low molecular weight heparin, is recommended at a therapeutic dose of 1 mg/kg subcutaneously twice a day to achieve effective anticoagulation in this setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Add long-acting nitrate:</span></strong><span style=\"font-size:12.0pt\"> While long-acting nitrates can help with angina symptoms, they are not the primary treatment for acute management in this scenario. The priority is to stabilize the patient and prevent further thrombotic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase metoprolol dose to 100mg BID:</span></strong><span style=\"font-size:12.0pt\"> Increasing the dose of metoprolol may help with angina control, but it does not address the underlying risk of thrombus formation and is not the immediate next step in managing high-risk unstable angina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add clopidogrel 75mg OD:</span></strong><span style=\"font-size:12.0pt\"> Clopidogrel is an antiplatelet agent that is beneficial in ACS, but in this acute setting, starting anticoagulation with enoxaparin takes precedence to prevent thrombus formation. Clopidogrel can be added as part of dual antiplatelet therapy later on.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with high-risk unstable angina, especially those with recurrent chest pain at rest and ECG changes, initiating therapeutic anticoagulation with enoxaparin is a critical step in the acute management to prevent thrombus formation and progression to myocardial infarction.</span></span></p>",
      "correct_choice_id": 45201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57277,
      "choices": [
        {
          "id": 228489,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Focal seizures: Lamotrigine, Carbamazepine, Phenytoin, Valproate </span></span></span></p>"
        },
        {
          "id": 228490,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Absence seizure: Carbamazepine Ethosuximide, Valproate </span></span></span></p>"
        },
        {
          "id": 228491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myoclonic seizures: Valproate, Lamotrigine, Clonazepam </span></span></span></p>"
        },
        {
          "id": 228492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Generalized tonic clonic seizures: Valproate, Lamotrigine, Topiramate, Phenytoin, Carbamazepine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Which of the following pairings of seizure type and anti-epileptic drug (AED) is incorrect? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q2311121",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439625,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Absence Seizures: Carbamazepine, Ethosuximide, Valproate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The incorrect pairing is Absence Seizures: Carbamazepine, Ethosuximide, Valproate. Carbamazepine is not used in the treatment of absence seizures; in fact, it can exacerbate them. Ethosuximide and Valproate are the appropriate first-line treatment options for absence seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selection of Anti-Epileptic Drugs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/1.jpg\" style=\"height:255px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alternatives</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/2.jpg\" style=\"height:401px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug of Choice for Various Types of Seizures</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/3.jpg\" style=\"height:457px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Focal Seizures</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Lamotrigine, Carbamazepine, Phenytoin, Valproate: This is a correct pairing, as all these drugs are used in the treatment of focal seizures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Myoclonic Seizures</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Valproate, Lamotrigine, Clonazepam: This is also a correct pairing, as these drugs are used to manage myoclonic seizures. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Generalized Tonic-Clonic Seizures</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">: Valproate, Lamotrigine, Topiramate, Phenytoin, Carbamazepine: This pairing is accurate as well, with all listed drugs being used to treat generalized tonic-clonic seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Carbamazepine is contraindicated in absence seizures and can worsen them. Ethosuximide and Valproate are the preferred first-line treatments for absence seizures.</span></span></span></p>",
      "correct_choice_id": 228490,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11533,
      "choices": [
        {
          "id": 46098,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed distal airway obstruction</span></p>"
        },
        {
          "id": 46099,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed central airway obstruction</span></p>"
        },
        {
          "id": 46100,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable intrathoracic obstruction</span></p>"
        },
        {
          "id": 46101,
          "text": "<p><span style=\"font-size:12.0pt;\">Variable extra thoracic obstruction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the pathology from the given flow-volume loop: (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-154508.png\" alt=\"\" width=\"300\" height=\"259\"></span></p>",
      "unique_key": "Q7690013",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439701,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Fixed central airway obstruction</strong></span></p><p><br><span style=\"font-size:12pt;\">The flow-volume loop shows flattening of both the inspiratory and expiratory limbs, which is characteristic of a fixed central airway obstruction. This pattern suggests an obstruction that affects airflow both during inhalation and exhalation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fixed distal airway obstruction</strong> would not typically affect both phases of the loop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Variable intrathoracic obstruction</strong> affects the expiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Variable extrathoracic obstruction</strong> affects the inspiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Flattening of both inspiratory and expiratory limbs in a flow-volume loop indicates a fixed central airway obstruction.</span></p>",
      "correct_choice_id": 46099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11475,
      "choices": [
        {
          "id": 45866,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluctuating cognition</span></p>"
        },
        {
          "id": 45867,
          "text": "<p><span style=\"font-size:12.0pt;\">REM sleep behavior disorder</span></p>"
        },
        {
          "id": 45868,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations</span></p>"
        },
        {
          "id": 45869,
          "text": "<p><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following are the core clinical features for the diagnosis of Lewy body dementia except:</span></p>",
      "unique_key": "Q9231937",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Orthostatic hypotension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lewy body dementia (LBD), also known as dementia with Lewy bodies, is characterized by specific core clinical features. Orthostatic hypotension, while commonly observed in LBD due to autonomic dysfunction, is not classified as a core clinical feature but rather as a supportive feature for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Central feature:&nbsp;</strong>Dementia (Essential for the diagnosis of DLB).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Core Clinical criteria include the following:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Fluctuating cognition with pronounced variations in attention and alertness.</span></li><li><span style=\"font-size:12.0pt;\">Recurrent visual hallucinations that are typically well formed and detailed.</span></li><li><span style=\"font-size:12.0pt;\">Rapid eye movement (REM) sleep behavior disorder (RBD).</span></li><li><span style=\"font-size:12.0pt;\">Spontaneous cardinal features of parkinsonism.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Supportive Features of LBD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Autonomic Dysfunction:&nbsp;</strong>Including orthostatic hypotension.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Severe Sensitivity to Antipsychotic Drugs:&nbsp;</strong>Patients may experience severe motor and neuroleptic sensitivity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other Hallucinations and Neurological Signs:&nbsp;</strong>Can include auditory hallucinations or transient, unexplained loss of consciousness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Onset of dementia preceding or</strong> <strong>within 1 year&nbsp;</strong>of onset of parkinsonism differentiates Lewy Body dementia from Parkinson's disease with dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fluctuating cognition:&nbsp;</strong>Fluctuating cognition is one of the hallmark symptoms of LBD, characterized by significant variations in attention and alertness. This fluctuation is more pronounced than what is typically seen in other forms of dementia, such as Alzheimer's disease, and can vary from hour to hour or day to day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. REM sleep behavior disorder:&nbsp;</strong>REM sleep behavior disorder (RBD) is a core feature of LBD, where patients physically act out their dreams, often vividly. This disorder is a result of the loss of normal muscle atonia that should occur during REM sleep, leading to potentially violent movements and vocalizations during sleep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Recurrent visual hallucinations:&nbsp;</strong>Visual hallucinations in LBD are typically well-formed and detailed, often involving people or animals. These hallucinations are a core feature and differ from the more nebulous or less structured hallucinations seen in other disorders. They are thought to be due to the underlying Lewy body pathology affecting cortical brain areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Orthostatic hypotension is a supportive, not core, criterion for the diagnosis of Lewy body dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21e/Neurology, DLB Chapter 434 /12305.</strong></span></p>",
      "correct_choice_id": 45869,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11798,
      "choices": [
        {
          "id": 47158,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right to left shunt</span></span></p>"
        },
        {
          "id": 47159,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventilation/Perfusion mismatch</span></span></p>"
        },
        {
          "id": 47160,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoventilation</span></span></p>"
        },
        {
          "id": 47161,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar membrane damage</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient came with hypoxemia and a normal alveolar-arterial oxygen gradient. What can be the cause? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q8889770",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439703,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypoventilation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxemia with a normal alveolar-arterial (A-a) oxygen gradient typically points to specific causes where the alveolar oxygen (PAO2) and arterial oxygen (PaO2) levels remain proportionate. In this scenario, the primary causes are hypoventilation and situations involving low inspired oxygen tension (low FiO2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hypoventilation:</span></strong><span style=\"font-size:12.0pt\"> This condition leads to hypoxemia due to inadequate ventilation. When ventilation is insufficient, the amount of oxygen entering the alveoli drops, leading to a corresponding decrease in the amount of oxygen diffusing into the blood, resulting in hypoxemia. However, because the underlying issue is with ventilation and not with oxygen diffusion or blood flow, the A-a gradient remains normal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low FiO2 or Low Barometric Pressure:</span></strong><span style=\"font-size:12.0pt\"> This can occur in scenarios such as high altitude where the barometric pressure is low, leading to reduced oxygen availability in the air. However, these situations were not explicitly listed among the answer choices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the reference paragraph, other conditions like ventilation/perfusion (V/Q) mismatch, diffusion limitation, and alveolar membrane damage, cause an increased A-a gradient due to impaired oxygen transfer across the alveolar membrane or mismatched ventilation and perfusion in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Right to left shunt:</strong> This condition causes hypoxemia due to blood bypassing the lungs and not getting oxygenated. It leads to an increased A-a gradient because the oxygen content of the arterial blood is significantly lower compared to the alveolar oxygen level.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Ventilation/Perfusion mismatch:</strong> This condition results from areas of the lung receiving oxygen but not perfused with blood or areas perfused with blood but not receiving oxygen. It causes an increased A-a gradient due to ineffective oxygen transfer to the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Alveolar membrane damage:</strong> This results in impaired oxygen diffusion across the alveolar-capillary membrane, leading to an increased A-a gradient as oxygen transfer from alveoli to blood is hindered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoventilation is a primary cause of hypoxemia with a normal alveolar-arterial oxygen gradient.</span></span></span></p>",
      "correct_choice_id": 47160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11713,
      "choices": [
        {
          "id": 46818,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical pneumonia</span></p>"
        },
        {
          "id": 46819,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung abscess</span></p>"
        },
        {
          "id": 46820,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis</span></p>"
        },
        {
          "id": 46821,
          "text": "<p><span style=\"font-size:12.0pt;\">Broncho pulmonary pneumonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common presentation of inhalational anthrax? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q7562893",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439704,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Hemorrhagic mediastinitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inhalational of anthrax spores (&lt;5 microns) are phagocytosed by alveolar macrophages, carried to local mediastinal lymph nodes releasing toxins causing hemorrhagic mediastinitis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is category A bioterrorism agent along with plague, botulism</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment recommended with IV antibiotics (Ciprofloxacin+Clindamycin)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Atypical pneumonia</strong> occurs in Chlamydia, Mycoplasma, Legionella pneumonia causing interstitial infiltrates</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Lung abscess</strong> is seen as complication of infection with anaerobes, complication of pneumonia, atypical organisms like burkholderia, Infective endocarditis with septic embolism</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Bronchopneumonia occurs due to pneumococcus</strong>, H.influenza etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis is the hallmark presentation of inhalational anthrax, indicating a severe systemic infection that requires immediate medical attention and aggressive antibiotic therapy. Awareness of this presentation is crucial, particularly in contexts involving potential exposure to anthrax spores, such as bioterrorism.</span></p>",
      "correct_choice_id": 46820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11751,
      "choices": [
        {
          "id": 46970,
          "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
        },
        {
          "id": 46971,
          "text": "<p><span style=\"font-size:12.0pt;\">Troponin-T</span></p>"
        },
        {
          "id": 46972,
          "text": "<p><span style=\"font-size:12.0pt;\">CKMB</span></p>"
        },
        {
          "id": 46973,
          "text": "<p><span style=\"font-size:12.0pt;\">BNP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the complaints of chest pain. Which among the following is the best investigation to diagnose MI within 2-4 hours? (INICET NOV 2020)</span></p>",
      "unique_key": "Q7231088",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439705,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Troponin – T</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Troponin-T is the most sensitive and specific biomarker available for diagnosing myocardial infarction (MI) within the early hours of symptom onset. It begins to rise within 3-4 hours of myocardial damage, peaks at around 12-48 hours, and remains elevated for up to 7-10 days, making it highly useful for early diagnosis and detection of recent heart damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. LDH:</strong>&nbsp;it is a less specific enzyme that may be elevated in many types of tissue damage and is not ideal for early diagnosis of MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CKMB: it&nbsp;</strong>rises within 4-8 hours of myocardial injury, making it less useful than Troponin-T in the very early stages post-symptom onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BNP:&nbsp;</strong>it is primarily used to assess heart failure and is not a primary marker for acute myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-110113.png\" alt=\"\" width=\"1000\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rise by &gt;20%of troponin is used for diagnosis of Reinfarction</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newer biomarkers: HFABP, miRNA1,21,33</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - (Cardiology/Biomarkers, MI)</strong></span></p>",
      "correct_choice_id": 46971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11265,
      "choices": [
        {
          "id": 45026,
          "text": "<p><span style=\"font-size:12.0pt;\">Class A</span></p>"
        },
        {
          "id": 45027,
          "text": "<p><span style=\"font-size:12.0pt;\">Class B</span></p>"
        },
        {
          "id": 45028,
          "text": "<p><span style=\"font-size:12.0pt;\">Class C</span></p>"
        },
        {
          "id": 45029,
          "text": "<p><span style=\"font-size:12.0pt;\">Class D</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the Child-Turcotte-Pugh (CTP) class for the patient who has a serum bilirubin 2.5 mg/dl, serum albumin 3 g/dL, prothrombin time 5 seconds (INR = 2), no encephalopathy, and mild ascites?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q4854419",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439706,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Class B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the Child-Turcotte-Pugh (CTP) score, each of the five clinical measures is scored with points from 1 to 3 based on specific criteria:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Bilirubin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">&lt;2 mg/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2-3 mg/dL = 2 points (Patient has 2.5 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\">3 mg/dL = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Albumin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">3.5 g/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2.8-3.5 g/dL = 2 points</span></li><li><span style=\"font-size:12.0pt;\">&lt;2.8 g/dL = 3 points (Patient has 3 g/dL, scoring 2 points)</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>INR:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">1-1.7 = 1 point</span></li><li><span style=\"font-size:12.0pt;\">1.8-2.3 = 2 points (Patient has INR = 2)</span></li><li><span style=\"font-size:12.0pt;\">2.3 = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Ascites:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point</span></li><li><span style=\"font-size:12.0pt;\">Controlled = 2 points (Patient has mild ascites, scoring 2 points)</span></li><li><span style=\"font-size:12.0pt;\">Refractory = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Encephalopathy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point (Patient has none)</span></li><li><span style=\"font-size:12.0pt;\">Grade 1-2 = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Grade 3-4 = 3 points</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Scoring Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bilirubin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Albumin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">INR = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Ascites = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Encephalopathy = 1 point</span><br><span style=\"font-size:12.0pt;\">Total = 9 points</span></li></ul><p><span style=\"font-size:12.0pt;\">The patient scores 9 points, placing them in Child-Turcotte-Pugh Class B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Child-Turcotte-Pugh scoring system</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-185922.jpg\" alt=\"\" width=\"1000\" height=\"462\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inference:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>CTP A:</strong> 5-6</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP B: </strong>7-9</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP C: </strong>10-15</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cirrhosis/Chapter 344</strong></span></p>",
      "correct_choice_id": 45027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50953,
      "choices": [
        {
          "id": 203353,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute HBV infection in window period&nbsp;</span></p>"
        },
        {
          "id": 203354,
          "text": "<p><span style=\"font-size:12.0pt;\">Immune with recombinant HBV Vaccine&nbsp;</span></p>"
        },
        {
          "id": 203355,
          "text": "<p><span style=\"font-size:12.0pt;\">HBV infection in the remote past, completely recovered&nbsp;</span></p>"
        },
        {
          "id": 203356,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection inactive carrier&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The blood investigation of a patient is given below. What is the probable diagnosis? (</span>INICET Nov 2023)</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBs - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive,</span></li><li><span style=\"font-size:12.0pt;\">HBeAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBe – NR (NR – Non reactive)</span></li></ul>",
      "unique_key": "Q1615461",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439707,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) HBV infection in the remote past, completely recovered</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's serological markers indicate the following:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - Non-Reactive (NR): This suggests that the patient is not currently infected with Hepatitis B.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBs - NR: Lack of antibodies against the Hepatitis B surface antigen suggests no current immunity from vaccination or recent infection.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR: The absence of IgM antibodies against the core antigen indicates no recent acute infection.</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive: Presence of total core antibodies (including IgG) indicates past exposure to the virus.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBeAg - NR: Absence of the e antigen suggests no active viral replication.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBe - NR: Absence of antibodies against the e antigen suggests no current or recent active infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these markers, the most likely scenario is that the patient had a Hepatitis B infection in the past and has completely recovered. The presence of Anti HBc total (which is predominantly IgG) signifies past infection. In cases of remote past infection, anti-HBs antibodies may fall below detectable levels, although the patient still has immunity through memory B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute HBV infection in window period:&nbsp;</strong>In the window period of acute HBV infection, Anti HBc IgM should be positive, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immune with recombinant HBV Vaccine:&nbsp;</strong>Patients vaccinated against HBV typically have positive Anti HBs and negative Anti HBc total, as they have not been exposed to the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic HBV infection inactive carrier:</strong>&nbsp;Chronic HBV infection requires the presence of HBsAg for more than six months. The absence of HBsAg rules out chronic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Anti HBc total (predominantly IgG) with all other markers negative suggests a past HBV infection that has completely resolved.</span></p>",
      "correct_choice_id": 203355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11876,
      "choices": [
        {
          "id": 47470,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caf&eacute; au lait spot</span></span></p>"
        },
        {
          "id": 47471,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary thyroid carcinoma</span></span></p>"
        },
        {
          "id": 47472,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathyroid adenoma</span></span></p>"
        },
        {
          "id": 47473,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic nerve glioma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is seen in MEN 2B syndrome? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5603946",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439708,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Medullary thyroid carcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by the presence of specific tumors and physical features. This syndrome is often referred to as &quot;Triple M syndrome&quot; because it commonly presents with three key features: mucosal neuromas, a marfanoid body habitus, and medullary thyroid carcinoma. In addition, pheochromocytomas may also occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is a type of thyroid cancer originating from the parafollicular cells (C cells) that produce calcitonin. MTC is a hallmark of MEN 2B, making it one of the primary diagnostic criteria for the syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is associated with mutations in the RET proto-oncogene, specifically the codon 918 mutation on chromosome 10, which leads to the development of these tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Caf&eacute; au lait spot:</span></strong><span style=\"font-size:12.0pt\"> Caf&eacute; au lait spots are not characteristic of MEN 2B syndrome. These pigmented skin lesions are more commonly associated with neurofibromatosis type 1 (NF1) and, in some cases, tuberous sclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathyroid adenoma:</span></strong><span style=\"font-size:12.0pt\"> Parathyroid adenomas are typically seen in patients with MEN 1 and MEN 2A syndromes, not in MEN 2B. These adenomas cause hyperparathyroidism, which is not a feature of MEN 2B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Optic nerve glioma:</span></strong><span style=\"font-size:12.0pt\"> Optic nerve gliomas are primarily associated with neurofibromatosis type 1 (NF1). They are not a feature of MEN 2B syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most significant feature of MEN 2B syndrome is the presence of medullary thyroid carcinoma, alongside mucosal neuromas and a marfanoid body habitus, often linked to mutations in the RET proto-oncogene</span></span></span></p>",
      "correct_choice_id": 47471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13102,
      "choices": [
        {
          "id": 52370,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratoconus</span></p>"
        },
        {
          "id": 52371,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratomalacia</span></p>"
        },
        {
          "id": 52372,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphyloma</span></p>"
        },
        {
          "id": 52373,
          "text": "<p><span style=\"font-size:12.0pt;\">Granular dystrophy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with glaucoma presents with a bulging cornea. What is the most likely diagnosis? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q9296066",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439709,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Staphyloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High intraocular pressure leads to the thinning of the ocular tissue, thereby resulting in a staphyloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Staphyloma:&nbsp;</strong>It is an abnormal protrusion of the uveal tissue through a weak and thin portion of the cornea or sclera. So, staphyloma is lined internally by uveal tissue and externally by weak cornea or sclera.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_NK8F4My.jpg\" alt=\"\" width=\"500\" height=\"237\"></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ciliary and equatorial staphylomas are most commonly associated with glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of Staphylomas&nbsp;&nbsp;&nbsp;&nbsp; -</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture110.jpg\" alt=\"\" width=\"1000\" height=\"419\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause for anterior staphyloma is sloughing corneal ulcer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause for posterior staphyloma is degenerative high axial myopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Keratoconus:</strong> This condition involves a progressive thinning and coning of the cornea, leading to visual distortion, but it is not typically associated with glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Keratomalacia:</strong> A severe form of vitamin A deficiency leading to corneal softening. The association between keratomalacia and glaucoma is not typical, as keratomalacia results primarily from nutritional deficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Granular dystrophy:</strong> A type of corneal dystrophy characterized by the accumulation of granular deposits in the cornea. It is a genetically inherited condition, unrelated to the thinning caused by glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Staphyloma, particularly anterior and ciliary types, can develop due to high intraocular pressure in glaucoma, leading to the protrusion of the uveal tissue through a weakened cornea or sclera.</span></p>",
      "correct_choice_id": 52372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57279,
      "choices": [
        {
          "id": 228497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Basilar artery</span></span></span></p>"
        },
        {
          "id": 228498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Vertebral artery</span></span></span></p>"
        },
        {
          "id": 228499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Posterior inferior cerebellar artery (PICA)</span></span></span></p>"
        },
        {
          "id": 228500,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Middle cerebral artery (MCA)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 62-year-old man with a history of hypertension and smoking presents to the emergency department with sudden onset of dizziness, difficulty swallowing, and slurred speech. He reports numbness on the right side of his face and left side of his body, along with blurred vision and a hoarse voice. On examination, he has right-sided Horner&#39;s syndrome (ptosis, miosis, and anhidrosis), right-sided facial numbness, dysphagia, hoarseness, and diminished gag reflex. His left arm and leg have impaired pain and temperature sensation. Which of the following arteries is most likely affected?</span></span></span></p>",
      "unique_key": "Q7433939",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439710,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: C. Posterior inferior cerebellar artery (PICA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The patient&rsquo;s symptoms are consistent with lateral medullary syndrome (Wallenberg syndrome), commonly due to thrombosis of the posterior inferior cerebellar artery (PICA). This condition involves multiple structures on the side of the lesion, including the vestibular nuclei (leading to vertigo and nausea), descending sympathetic tract (resulting in Horner&rsquo;s syndrome), trigeminal nerve nucleus (causing facial numbness), and cranial nerves IX and X (causing dysphagia and hoarseness). Additionally, contralateral spinothalamic tract involvement results in impaired pain and temperature sensation on the opposite side of the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Basilar artery</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A basilar artery stroke often affects the pons and midbrain, leading to severe symptoms such as locked-in syndrome, cranial nerve abnormalities, and quadriplegia, which do not match this patient&rsquo;s presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. Vertebral artery</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Vertebral artery strokes can cause a wide variety of brainstem and cerebellar symptoms, but they often present with more diffuse findings compared to PICA strokes. They can sometimes contribute to PICA infarction, but specific involvement of lateral medullary structures like those described here is most characteristic of isolated PICA occlusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Middle cerebral artery (MCA)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">MCA strokes typically involve the cerebral cortex, presenting with contralateral motor and sensory deficits, aphasia (if the dominant hemisphere is involved), and neglect (if the non-dominant hemisphere is affected). They do not cause the brainstem symptoms described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lateral medullary syndrome (Wallenberg syndrome) results from thrombosis of the posterior inferior cerebellar artery (PICA) and presents with a distinctive pattern of cranial nerve deficits, ipsilateral Horner&rsquo;s syndrome, and contralateral loss of pain and temperature sensation. Understanding the unique symptomatology of brainstem stroke syndromes aids in prompt recognition and management.</span></span></span></p>",
      "correct_choice_id": 228499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5761,
      "choices": [
        {
          "id": 23015,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low MSAFP, high hCG, low UE3</span></span></span></p>"
        },
        {
          "id": 23016,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High MSAFP, low hCG, high UE3</span></span></span></p>"
        },
        {
          "id": 23017,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low MSAFP, high hCG, high UE3</span></span></span></p>"
        },
        {
          "id": 23018,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High MSAFP, low hCG, low UE3</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman has a fetus with Down&#39;s syndrome. Triple test done at 15-16 weeks will have?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9975201",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439731,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Low MSAFP, high hCG, low UE3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The triple and quadruple test is done between 15 &ndash; 21 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of Triple test are: Free &beta; hCG, unconjugated Estriol (uE3) and Maternal Serum &alpha;-fetoprotein.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the Quadruple test are: Free &beta; hCG, unconjugated Estriol (uE3), Maternal Serum &alpha;-fetoprotein. And Inhibin A.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/untitled-296.jpg\" style=\"height:146px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">*Easy to remember: <strong>B</strong> for <strong>B</strong>ig; so in Down&rsquo;s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The triple test results for Down&#39;s syndrome typically show low MSAFP, high hCG, and low uE3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 859, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23015,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10268,
      "choices": [
        {
          "id": 41038,
          "text": "<p><span style=\"font-size:12.0pt;\">Alert, pulse, grimace, activity, respiration</span></p>"
        },
        {
          "id": 41039,
          "text": "<p><span style=\"font-size:12.0pt;\">Assessment, pulse, grimace, alive, respiration</span></p>"
        },
        {
          "id": 41040,
          "text": "<p><span style=\"font-size:12.0pt;\">Appearance, pulse, grimace, activity, respiration</span></p>"
        },
        {
          "id": 41041,
          "text": "<p><span style=\"font-size:12.0pt;\">Appearance, pressure, grimace, activity, respiration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most appropriate expansion of Apgar is: (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4438131",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439782,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Appearance, pulse, grimace, activity, respiration</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The expansion of Apgar is appearance, pulse, grimace, activity and respiration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-155857.png\" alt=\"\" width=\"1000\" height=\"454\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture4_ZuwodDk.jpg\" alt=\"\" width=\"700\" height=\"468\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The APGAR score is a quick assessment of a newborn's overall health and well-being immediately after birth. The score is based on a five-point scale that evaluates the newborn's appearance, pulse, grimace, activity, and respiration. Each category is scored from 0-2, and the total score ranges from 0-10. A score of 7 or above is considered normal, while a score of 4-6 indicates that the newborn may require some medical attention, and a score of 3 or below indicates that the newborn requires immediate medical attention. The APGAR score is typically assessed at 1 and 5 minutes after birth and may be repeated if necessary.Top of FormBottom of Form</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Apgar score assesses a newborn's health based on five criteria: Appearance, Pulse, Grimace, Activity, and Respiration.</span></p>",
      "correct_choice_id": 41040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10160,
      "choices": [
        {
          "id": 40606,
          "text": "<p><span style=\"font-size:12.0pt;\">Intussusception</span></p>"
        },
        {
          "id": 40607,
          "text": "<p><span style=\"font-size:12.0pt;\">Volvulus</span></p>"
        },
        {
          "id": 40608,
          "text": "<p><span style=\"font-size:12.0pt;\">Duodenal atresia</span></p>"
        },
        {
          "id": 40609,
          "text": "<p><span style=\"font-size:12.0pt;\">Intestinal obstruction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A baby presented with abdominal pain. On examination, a mass is palpated in the right lumbar region. A barium enema is done, and the image is given below. What is the likely diagnosis? (NEET PG 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/17/untitled-457.jpg\" alt=\"\" width=\"300\" height=\"303\"></p>",
      "unique_key": "Q2027482",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439783,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Intussusception</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Intussusception&nbsp;</strong>is a condition where a portion of the bowel is telescoped into an adjacent segment, with the apex of the intussusceptum being more prone to ischemia which leads to gangrene. The most common location of intussusception is ileocolic. It is commonly seen in infants during the weaning period following the introduction of new food, vaccination, or upper respiratory tract infection. The currently approved rotavirus vaccines are associated with very minimal risk of intussusception. An area of enlarged submucosal Peyer's patch acts as a lead point for intussusception.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The clinical scenario&nbsp;</strong>of pain abdomen with a palpable mass in the right lumbar region along with the barium enema showing claw sign is suggestive of intussusception. Some lead points in children are Meckel's diverticulum, intestinal polyp, inflamed appendix, submucosal hemorrhage seen in Henoch-Schonlein purpura, and intestinal duplication cysts. Patients usually present with cramping abdominal pain, palpable sausage-shaped abdominal mass, vomiting, and passage of red currant jelly stools.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis&nbsp;</strong>is confirmed by abdominal ultrasound which shows the target sign bull's eye sign and pseudokidney sign. <strong>Management</strong> of intussusception includes prompt referral to a pediatric surgeon for reduction by air or contrast enema or surgical intervention if there is a failure of non-operative reduction or clinical instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Volvulus:&nbsp;</strong>Volvulus, specifically sigmoid volvulus, shows a characteristic \"coffee bean\" sign on imaging. It involves the twisting of the intestine around itself, which can lead to obstruction and ischemia but presents differently on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Duodenal Atresia:&nbsp;</strong>Duodenal atresia typically presents with a \"double bubble\" sign on imaging, which results from the dilatation of the stomach and proximal duodenum. This condition leads to bilious vomiting and is evident soon after birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intestinal Obstruction:&nbsp;</strong>General intestinal obstruction shows multiple air-fluid levels on imaging, which is different from the claw sign seen in intussusception.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intussusception presents with cramping abdominal pain, palpable mass, and red currant jelly stools, and is confirmed by imaging showing the claw sign.</span></p>",
      "correct_choice_id": 40606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20499,
      "choices": [
        {
          "id": 81958,
          "text": "<p><span style=\"font-size:12pt;\">Transverse vaginal septum above the vagina</span></p>"
        },
        {
          "id": 81959,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal atresia</span></p>"
        },
        {
          "id": 81960,
          "text": "<p><span style=\"font-size:12pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 81961,
          "text": "<p><span style=\"font-size:12pt;\">Cervical agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presents in OPD with complaints of cyclical pain in abdomen. &nbsp;On examination, a suprapubic bulge can be seen in the pelvic area. PR examination reveals a swelling in the anterior aspect. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q1602870",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439784,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Imperforate hymen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given case scenario points to a diagnosis of cryptomenorrhea, due to an imperforate hymen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cryptomenorrhea is a condition in which menstruation occurs but is not visible due to obstruction of the outflow tract resulting in either hematometra (blood collection within the uterus) or hematocolpos (blood collection within vagina). In the long term, it may result in endometriosis, urinary retention and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>IMPERFORATE HYMEN</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Presents as cryptomenorrhea</span></li><li><span style=\"font-size:12pt;\">H/o cyclical abdominal pain/cyclical dysmenorrhea</span></li><li><span style=\"font-size:12pt;\">Local examination: bluish bulge with intact hymen</span></li><li><span style=\"font-size:12pt;\">On P/R: swelling (hematocolpos) felt along length of vagina anteriorly</span></li><li><span style=\"font-size:12pt;\">Treatment: Cruciate incision.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-182236.png\" alt=\"\" width=\"400\" height=\"471\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In Imperforate hymen, swelling is seen all along the length of the vagina on PR examination as there is hematocolpos (blood in the vagina)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Transverse vaginal septum</strong>: Transverse vaginal septum is a Müllerian anomaly. On examination, blind vagina is found. No tense blue hymen and cough impulse will be absent. Diagnosis can be confirmed by MRI</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Vaginal atresia</strong>: If vaginal introitus is not seen, then it’s vaginal atresia</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cervical agenesis</strong>: Cervical agenesis will show absence of a cervix is on examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Imperforate hymen presents with cryptomenorrhea, characterized by cyclical abdominal pain and hematocolpos due to obstruction of menstrual flow, with a suprapubic bulge and anterior swelling palpable on PR examination.</span></p>",
      "correct_choice_id": 81960,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49035,
      "choices": [
        {
          "id": 195715,
          "text": "<p><span style=\"font-size:18px;\">Opium</span></p>"
        },
        {
          "id": 195716,
          "text": "<p><span style=\"font-size:18px;\">Cannabis</span></p>"
        },
        {
          "id": 195717,
          "text": "<p><span style=\"font-size:18px;\">Magic Mushroom</span></p>"
        },
        {
          "id": 195718,
          "text": "<p><span style=\"font-size:18px;\">Cocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>In the 18th century, the East India Company engaged in the illicit trade of a specific substance with China, which played a significant role in the historical trade dynamics. What was the substance that the company smuggled into China during this time? </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
      "unique_key": "Q8008358",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439785,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Opium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">In 18<sup>th</sup> &amp; 19<sup>th</sup> centuaries, EIC (East India Company) used to purchase Tea against Silver.&nbsp;</span></li><li><span style=\"font-size:18px;\">By opium export, EIC were able to save their Silver and purchased tea against Opium.</span></li><li><span style=\"font-size:18px;\">Opium is derived from the poppy plant and has been used both medicinally and recreationally.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Cannabis: Marijuana, a</strong> psychoactive drug from the Cannabis plant, used both recreationally and medicinally around the world.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Magic Mushrooms</strong>: Refer to various types of mushrooms that contain psilocybin, a psychoactive compound. These have been used for centuries for their hallucinogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Cocaine</strong>: Derived from the coca plant, cocaine is a powerful stimulant used primarily as a recreational drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective</strong> :</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In 18<sup>th</sup> century British East India company used to transport opium to China .</span></p>",
      "correct_choice_id": 195715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32291,
      "choices": [
        {
          "id": 129022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nutritional rickets </span></span></span></span></p>"
        },
        {
          "id": 129023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets </span></span></span></span></p>"
        },
        {
          "id": 129024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type I </span></span></span></span></p>"
        },
        {
          "id": 129025,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type II</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy presented with developmental delay, recurrent chest infections and worsening bony pain. His serum PTH was normal. Calcium was normal and phosphate was low. There is no response to Vitamin D. The probable diagnosis is:(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q3333338",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439787,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) X-linked hypophosphatemic rickets</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets is a genetic disorder characterized by low phosphate levels in the blood due to impaired phosphate reabsorption by the kidneys. This condition can lead to bone deformities, bony pain, and growth delays. Normal PTH levels are consistent with this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Nutritional rickets</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nutritional rickets is typically caused by a deficiency of Vitamin D, calcium, or phosphate. In this case, the boy has normal serum PTH, which suggests that his body is not compensating for a Vitamin D deficiency. Additionally, his phosphate levels are low despite Vitamin D supplementation, which is not characteristic of nutritional rickets.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Vitamin D dependent rickets type I</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is caused by a genetic mutation that impairs the conversion of Vitamin D to its active form. It usually presents with low calcium levels and elevated PTH, which is not in line with the boy&#39;s normal PTH levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Vitamin D dependent rickets type II</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D dependent rickets type II is another genetic disorder that affects the body&#39;s response to Vitamin D. It can lead to low calcium levels and elevated PTH, which do not match the boy&#39;s normal PTH levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></u></strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked hypophosphatemic rickets is a genetic disorder that results in low phosphate levels and can present with bony pain, developmental delay, and recurrent infections. It is distinct from other forms of rickets due to its genetic basis and the characteristic low phosphate levels in the absence of Vitamin D response.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- https://www.ncbi.nlm.nih.gov/books/NBK562285/ </span></span></strong></p>",
      "correct_choice_id": 129023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6487,
      "choices": [
        {
          "id": 25917,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 25918,
          "text": "<p><span style=\"font-size:12.0pt;\">Sotalol</span></p>"
        },
        {
          "id": 25919,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 25920,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antiarrhythmic drugs is contraindicated in a patient with interstitial lung disease? (NEET PG 2020)</span></p>",
      "unique_key": "Q7671764",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439788,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amiodarone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiodarone is a class III anti arrhythmic drug. One of the adverse effects of amiodarone that is seen with long term therapy is pulmonary fibrosis, which can be rapidly progressive. Therefore, it is contraindicated in patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The other adverse effects include hepatotoxicity, hypothyroidism or hyperthyroidism (Amiodarone is 40% iodine by weight), blue grey skin pigmentation, corneal deposits, constipation and bradycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sotalol</strong>: Sotalol is also a class III antiarrhythmic agent but does not have the same risk of pulmonary toxicity as amiodarone. It is generally considered safer for patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Quinidine</strong>: Quinidine is a class I antiarrhythmic drug that is not associated with pulmonary toxicity. It has other potential side effects but is not contraindicated in interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lignocaine</strong>: Lignocaine (lidocaine) is a class Ib antiarrhythmic agent primarily used for ventricular arrhythmias. It does not have pulmonary toxicity and is not contraindicated in patients with interstitial lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Amiodarone is contraindicated in patients with interstitial lung disease due to its potential to cause pulmonary fibrosis, a serious and potentially irreversible adverse effect. It is essential to consider this risk when prescribing antiarrhythmic therapy to patients with pre-existing lung conditions.</span></p>",
      "correct_choice_id": 25917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57280,
      "choices": [
        {
          "id": 228501,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replace amlodipine and hydrochlorothiazide with losartan and a different diuretic, and add polyethylene glycol for constipation. </span></span></p>"
        },
        {
          "id": 228502,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue sertraline and olanzapine, start a new antidepressant and antipsychotic, and add polyethylene glycol. </span></span></p>"
        },
        {
          "id": 228503,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue current medications and add senna for constipation relief. </span></span></p>"
        },
        {
          "id": 228504,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop all medications and initiate corticosteroid therapy.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 72-year-old male with a history of high blood pressure and recent mood fluctuations presents with persistent difficulty passing stool. His blood pressure is elevated while sitting but drops significantly when lying down. He is currently taking amlodipine, hydrochlorothiazide, sertraline, olanzapine, and psyllium husk. Which of the following interventions is most appropriate? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q1368323",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439789,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A. Replace amlodipine and hydrochlorothiazide with losartan and a different diuretic, and add polyethylene glycol for constipation.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The patient is experiencing orthostatic hypotension, indicated by the significant drop in blood pressure when changing from sitting to lying down. This could be a side effect of his antihypertensive medications (amlodipine and hydrochlorothiazide). Additionally, constipation could be exacerbated by these medications or the antipsychotic olanzapine.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The best approach is to address both issues simultaneously. Switching to an angiotensin receptor blocker (ARB) like losartan can help manage hypertension while minimizing the risk of orthostatic hypotension. Changing to a different diuretic can further mitigate the risk of low blood pressure upon standing. Adding polyethylene glycol, an osmotic laxative, can effectively relieve constipation without interacting with other medications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Changing psychotropic medications might not be the primary concern, as the orthostatic hypotension and constipation may be primarily medication-related.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Adding senna without addressing the medications causing orthostatic hypotension might not be the most effective approach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Stopping all medications abruptly and starting steroids is not recommended as it can lead to withdrawal symptoms and other complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In elderly patients with orthostatic hypotension and constipation, consider adjusting medications that may contribute to these issues. Look for alternative antihypertensives and constipation relief options that have a lower risk of side effects and drug interactions</span></span></p>",
      "correct_choice_id": 228501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54792,
      "choices": [
        {
          "id": 218633,
          "text": "<p><span style=\"font-size:12.0pt;\">PKA → cAMP → adenylyl cyclase</span></p>"
        },
        {
          "id": 218634,
          "text": "<p><span style=\"font-size:12.0pt;\">cAMP → Adenylyl cyclase → PKA</span></p>"
        },
        {
          "id": 218635,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenylyl cyclase → cAMP → PKA</span></p>"
        },
        {
          "id": 218636,
          "text": "<p><span style=\"font-size:12.0pt;\">PKA→ Adenylyl cyclase → cAMP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Select the correct sequence: (INICET MAY 2024)</span></p>",
      "unique_key": "Q7936851",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439860,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenylyl cyclase → cAMP → PKA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sequence involves the activation of a G protein-coupled receptor pathway. When a hormone binds to its receptor, the associated heterotrimeric G protein undergoes a conformational change. This change leads to the exchange of GDP for GTP on the G protein's alpha subunit, causing it to dissociate from the beta and gamma subunits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The activated GTP-bound alpha subunit then interacts with adenylyl cyclase, an enzyme located on the inner membrane of the cell. Adenylyl cyclase converts ATP into cyclic AMP (cAMP). The newly formed cAMP acts as a secondary messenger that activates Protein Kinase A (PKA). PKA, in turn, phosphorylates various target proteins, leading to a cascade of cellular responses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence in the G protein-coupled receptor pathway is: Adenylyl cyclase activates the conversion of ATP to cAMP, which then activates Protein Kinase A (PKA).</span></p>",
      "correct_choice_id": 218635,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14641,
      "choices": [
        {
          "id": 58525,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 1</span></p>"
        },
        {
          "id": 58526,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 2</span></p>"
        },
        {
          "id": 58527,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 3</span></p>"
        },
        {
          "id": 58528,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image below shows a pressure sore. Which stage does this belong to?(NEET PG 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns30.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q2911595",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439861,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Stage 4</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given image shows a pressure sore with extensive tissue destruction, including damage to the muscle layer and thus it belongs to stage 4.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/333.jpg\" alt=\"\" width=\"1000\" height=\"514\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical Features:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Stage 1:</strong> Non-blanchable erythema of intact skin. Redness that does not fade when pressure is applied.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage 2:</strong> Partial-thickness skin loss with exposed dermis. The wound bed is viable, pink or red, and moist.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage 3:</strong> Full-thickness skin loss. Subcutaneous fat may be visible, but bone, tendon, or muscle are not exposed.</span></li><li><span style=\"font-size:12pt;\"><strong>Stage 4:</strong> Full-thickness skin and tissue loss. Exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone in the ulcer.</span></li><li><span style=\"font-size:12pt;\"><strong>Unstageable:</strong> Obscured full-thickness skin and tissue loss. Extent of tissue damage within the ulcer cannot be confirmed because it is obscured by slough or eschar.</span></li><li><span style=\"font-size:12pt;\"><strong>Deep Tissue Pressure Injury:</strong> Persistent non-blanchable deep red, maroon, or purple discoloration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Treatment Focus:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Patient Optimization:</strong> Addressing poor nutrition and managing ongoing medical problems.</span></li><li><span style=\"font-size:12pt;\"><strong>Preventative Measures:</strong> Implementing strategies to prevent further pressure injuries.</span></li><li><span style=\"font-size:12pt;\"><strong>Debridement:</strong> Removing necrotic tissue if appropriate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the extensive tissue destruction shown in the image, with damage extending through the muscle layer, the pressure sore is classified as a Stage 4 pressure injury.</span></p>",
      "correct_choice_id": 58528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9847,
      "choices": [
        {
          "id": 39354,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Ochronisis</span></span></span></p>"
        },
        {
          "id": 39355,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Metallosis</span></span></span></p>"
        },
        {
          "id": 39356,
          "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Malignant melanoma</span></span></span></p>"
        },
        {
          "id": 39357,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Rosai Dorfman disease</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman who had undergone total knee replacement surgery comes with complaints of knee pain with the loosening of implants. The following histopathological slide was obtained which showed foreign body giant cells along with the appearance highlighted in the image below. What is your diagnosis? (AIIMS MAY 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/979.jpg\" style=\"height:290px; width:469px\" /></span></span></p>",
      "unique_key": "Q8329567",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439862,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Metallosis</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The given clinical scenario and image with the said foreign body giant cell point towards a diagnosis of metallosis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Metallosis is an uncommon complication following total joint replacements of high wear joints like hip and knees. It occurs when metallic components in medical implants, specifically joint replacements, abrade against one another. The metal from the prosthesis infiltrates the bone and soft tissue surrounding it resulting in pain or squeaking on weight bearing or loosening of implant. Sometimes it may be asymptomatic with imaging findings (<strong><em>cloud sign or bubble sign</em>)</strong>. Aspiration reveals dark fluid consisting of metallic debris.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Ochronosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ochronosis is a metabolic disorder characterized by the deposition of homogentisic acid in connective tissues, leading to pigmentation and arthritis. It is not associated with metallic debris or foreign body giant cells.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Malignant melanoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Malignant melanoma is a type of skin cancer that would present with different histological findings, such as atypical melanocytes. It does not involve foreign body giant cells or metallic debris.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Rosai-Dorfman disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare disorder characterized by massive lymphadenopathy and histiocytosis with distinctive histological features, including the presence of histiocytes that exhibit emperipolesis. It does not involve metallic particles or joint replacements.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metallosis is a rare complication of joint replacement surgeries, characterized by the release of metallic debris from implants, leading to a foreign body reaction with the formation of foreign body giant cells and potential loosening of the implant.</span></span></span></p>",
      "correct_choice_id": 39355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7465,
      "choices": [
        {
          "id": 29828,
          "text": "<p><span style=\"font-size:12pt;\">Anterior nerve roots are more commonly involved</span></p>"
        },
        {
          "id": 29829,
          "text": "<p><span style=\"font-size:12pt;\">Mucous membranes within the affected dermatomes are involved</span></p>"
        },
        {
          "id": 29830,
          "text": "<p><span style=\"font-size:12pt;\">The lesions are not infectious</span></p>"
        },
        {
          "id": 29831,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal dermatome is most commonly affected</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is correct regarding the diagnosis based on the given image?&nbsp;</span>&nbsp;(NEET PG 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/438.jpg\" alt=\"\" width=\"400\" height=\"237\"></span></p>",
      "unique_key": "Q4100553",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439863,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B. Mucous membranes within the affected dermatomes are involved</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The above image shows confluent, red, pustular lesions in a single dermatome suggestive of <strong>herpes zoster or shingles</strong>. The <strong>mucous membranes</strong> within the affected dermatomes are <strong>involved.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Varicella-zoster virus (VZV)&nbsp;</strong>is a human herpesvirus that causes <strong>varicella (chickenpox</strong>) as a primary infection and then remains in a latent form in the dorsal root ganglia&nbsp;<strong>(NOT Anterior nerve roots)&nbsp;</strong>for a variable period after which it can reactivate to cause herpes zoster (shingles) which leads to <strong>vesicular lesions that are grouped together in a dermatomal / Segmental distribution as shown in the image below.</strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture3999.jpg\" alt=\"\" width=\"300\" height=\"231\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Herpes zoster:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Thoracic dermatome&nbsp;</strong>is most commonly affected <strong>(NOT Trigeminal).</strong></span></li><li><span style=\"font-size:12.0pt;\">The rash is restricted to a dermatome, but sometimes a few chickenpox‐type lesions can be found elsewhere. <strong>The lesions are infectious</strong></span></li><li><span style=\"font-size:12.0pt;\">The <strong>mucous membranes</strong> within the affected dermatomes are <strong>involved.</strong></span></li><li><span style=\"font-size:12.0pt;\">The <strong>first symptom of zoster is usually pain</strong>, 1-3 days after which the lesions appear. The patients are infectious, both from the virus in the lesions and nasopharynx.</span></li><li><span style=\"font-size:12.0pt;\">The dermatomes of <strong>T3 to L3 spinal segments are most affected in all ages</strong>. The <strong>posterior nerve roots and ganglia</strong> show inflammatory changes.</span></li><li><span style=\"font-size:12.0pt;\">Zoster is a self-limiting infection but it is painful and carries a risk of secondary infection and post-herpetic neuralgia. <strong>Analgesia and treatment of secondary infections are sufficient for mild infections.</strong></span></li></ul><p><span style=\"font-size:12pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Indications for antivirals in VZV (Acyclovir 800 mg):</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Painful zoster infections in adults</span></li><li><span style=\"font-size:12.0pt;\">Facial zoster at any age</span></li><li><span style=\"font-size:12.0pt;\">Immunocompromised</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The commonest and most intractable complication of zoster is post-herpetic neuralgia. It is generally defined as persistence or recurrence of pain more than 1-3 months after the onset of zoster. <strong>Post-herpetic neuralgia is most frequent when the trigeminal nerve is involved</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Anterior nerve roots are more commonly involved: False.</strong> In herpes zoster, it is the dorsal (posterior) nerve roots and ganglia that are predominantly involved, not the anterior nerve roots. The virus remains latent in the dorsal root ganglia and reactivates there, leading to symptoms in the corresponding dermatomal distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. The lesions are not infectious: False.</strong> The lesions of herpes zoster are highly infectious, particularly when the blisters are open and the fluid is accessible. The virus contained in these lesions can infect individuals who have not previously had chickenpox or the vaccine, leading to varicella (chickenpox).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Trigeminal dermatome is most commonly affected: False.</strong> While the trigeminal dermatome can be significantly affected (especially concerning due to the risk of herpes zoster ophthalmicus if the ophthalmic branch is involved), it is not the most commonly affected dermatome. The thoracic dermatomes are more frequently involved in herpes zoster cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Herpes zoster</strong>, commonly involves reactivation of the <strong>varicella-zoster virus </strong>within the <strong>dorsal root ganglion</strong>, leading to <strong>painful cutaneous eruptions </strong>that can affect <strong>mucous membranes </strong>within the involved <strong>dermatomes</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Herpes zoster lesions are <strong>infectious</strong>, particularly to those who are <strong>not immune to varicella-zoster virus</strong>, and <strong>thoracic dermatome </strong>is the <strong>most frequently </strong>affected area.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reference: Rook's Textbook of Dermatology 9th edition, Page no. 25.27-25.28</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison's Principles of Internal Medicine 20th Edition, Page no 106</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology 9th edition, Page no 4.13</strong></span></p>",
      "correct_choice_id": 29829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3678,
      "choices": [
        {
          "id": 14691,
          "text": "<p><span style=\"font-size:12.0pt;\">Buffy coat is used to diagnose the parasite</span></p>"
        },
        {
          "id": 14692,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an obligate extracellular parasite</span></p>"
        },
        {
          "id": 14693,
          "text": "<p><span style=\"font-size:12.0pt;\">It is transmitted from sheep</span></p>"
        },
        {
          "id": 14694,
          "text": "<p><span style=\"font-size:12.0pt;\">Stibogluconate is the first line of treatment in India</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Bone marrow aspirate of a patient shows the following features. Which of the following is true?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span> <span style=\"font-size:12.0pt;\">NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-274.jpg\" alt=\"\" width=\"442\" height=\"351\"></span></p>",
      "unique_key": "Q3888825",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Buffy coat is used to diagnose the parasite</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows the amastigote form of leishmaniasis located intracellularly in macrophages. Buffy coat is used to diagnose the parasite.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Buffy coat is the portion of blood that contains concentrates of white blood cells, including monocytes and platelets, and for obvious reasons its smear can be examined for detection of L. donovani bodies in suspected VL patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Detection of Leishmania donovani bodies in peripheral blood buffy coat smears is an alternative and minimally invasive procedure for the parasitological diagnosis of VL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCR assay with buffy coat preparations to detect Leishmania DNA has been found to be 10 times more sensitive than that with whole-blood preparation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serodiagnosis is a valid and the detection in serum and urine specimens of antileishmanial <strong>antibody against recombinant antigens such as rK39 by rapid immunochromatographic tests</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aldehyde test of Napier: Widely used for surveillance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serological tests for diagnosis: Rapid dipstick test, Direct agglutination test, ELISA, Indirect Fluorescent Antibody Test</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Leishmanin (<strong>Montenegro</strong>) test: Induration of <strong>5mm or more</strong> is considered positive, usually positive 4-6 weeks after onset in cutaneous leishmaniasis, valuable for distinguishing immune from nonimmune subjects and endemicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is an obligate extracellular parasite:</strong> This is incorrect. Leishmania donovani is an intracellular parasite that resides within macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is transmitted from sheep:</strong> This is incorrect. Leishmania is transmitted by the bite of infected female phlebotomine sandflies, not by sheep.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Stibogluconate is the first line of treatment in India:</strong> This is partially outdated. Sodium stibogluconate was once the first line of treatment, but now liposomal amphotericin B and miltefosine are commonly used as first-line treatments in India due to increased resistance to antimonials.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Buffy coat is used to diagnose Leishmania donovani by detecting the amastigote form in intracellular macrophages in patients with visceral leishmaniasis.</span></p>",
      "correct_choice_id": 14691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16092,
      "choices": [
        {
          "id": 64328,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 64329,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3,4,2</span></p>"
        },
        {
          "id": 64330,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4,3,2</span></p>"
        },
        {
          "id": 64331,
          "text": "<p><span style=\"font-size:12.0pt;\">4,3,2,1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the structures of the cubital fossa in sequence from medial to lateral? (</span>INICET Nov 2022)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Median nerve</span></p><p><span style=\"font-size:12.0pt;\">2. Radial nerve</span></p><p><span style=\"font-size:12.0pt;\">3. Tendon of biceps brachi</span></p><p><span style=\"font-size:12.0pt;\">4. Brachial artery</span></p>",
      "unique_key": "Q8022491",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439865,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 1,4,3,2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structures are arranged in the cubital fossa from medial to lateral as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Median nerve</span></p><p><span style=\"font-size:12.0pt;\">2. Brachial artery</span></p><p><span style=\"font-size:12.0pt;\">3. Tendon of biceps brachii</span></p><p><span style=\"font-size:12.0pt;\">4. Radial nerve (Superficial Branch of radial nerve)</span></p><p><span style=\"font-size:12.0pt;\">Mnemonic is MBBR</span><br>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-13.jpg\" alt=\"\" width=\"500\" height=\"346\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cubital fossa is actually a triangular area located on the anterior aspect of the elbow, not the upper forearm. It is bounded by several structures, including:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The lateral border of the pronator teres muscle, which forms the medial boundary</span></li><li><span style=\"font-size:12.0pt;\">The medial border of the brachioradialis muscle, which forms the lateral boundary</span></li><li><span style=\"font-size:12.0pt;\">The imaginary line connecting the epicondyles of the humerus, which forms the superior boundary</span></li><li><span style=\"font-size:12.0pt;\">The floor of the cubital fossa is formed by the brachialis and supinator muscles, while the roof is formed by the Deep fascia of the skin.</span></li><li><span style=\"font-size:12.0pt;\">The roof of cubital fossa contains Subcutaneous veins which are used for routine phlebotomy procedures. These veins are - median cubital vein, cephalic vein and basilic vein</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cubital fossa contains several important structures, including the brachial artery, radial nerve, and median nerve. It is a common site for blood draws and intravenous catheter placement due to the relatively superficial location of the structures and ease of access.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-14.jpg\" alt=\"\" width=\"500\" height=\"365\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-15.jpg\" alt=\"\" width=\"500\" height=\"289\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11pt;\">The correct anatomical sequencing of structures in the cubital fossa from medial to lateral—median nerve, brachial artery, tendon of biceps brachii, and radial nerve—is essential for both anatomical education and practical clinical applications.</span></p>",
      "correct_choice_id": 64330,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21888,
      "choices": [
        {
          "id": 87520,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 87521,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriatic arthritis</span></p>"
        },
        {
          "id": 87522,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankylosing spondylitis</span></p>"
        },
        {
          "id": 87523,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget’s disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 26-year-old male presents with back ache, morning stiffness and reddening of eyes. X-ray of the patient is given below. Identify the diagnosis of this patient:&nbsp;</span>(NEET PG 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/26/untitled-1367961.jpg\" alt=\"\" width=\"300\" height=\"412\"></p>",
      "unique_key": "Q4095831",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439866,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ankylosing spondylitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ANKYLOSING SPONDYLITIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Also known as <strong>Marie-Strumpell or Bechterew’s disease</strong>.</span></li><li><span style=\"font-size:12.0pt;\">It is a <strong>seronegative spondyloarthropathy.</strong></span></li><li><span style=\"font-size:12.0pt;\">It is a <strong>chronic inflammatory disease affecting the spine and sacroiliac joints</strong>.</span></li><li><span style=\"font-size:12.0pt;\">It also have a variable involvement of root joints (shoulder and hip) and peripheral joints.</span></li><li><span style=\"font-size:12.0pt;\">The involvement is an <strong>enthesopathy</strong>.</span></li><li><span style=\"font-size:12.0pt;\">HLA B27 is positive in 90% patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sacroiliitis is the earliest manifestation</strong> with features of both enthesitis and synovitis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Joints Involved:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Primarily affects axial skeleton.</span></li><li><span style=\"font-size:12.0pt;\">The disease usually <strong>begins in the sacroiliac joints</strong> and usually extends upwards to involve the lumbar, thoracic, and often cervical spine.</span></li><li><span style=\"font-size:12.0pt;\">Hip joint is the most commonly affected peripheral joint.</span></li><li><span style=\"font-size:12.0pt;\">Rarely, knee and ankle are also involved.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation:</strong></span><ul><li><span style=\"font-size:12.0pt;\">It is most commonly seen in young males aged 15-25 years.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Most common symptom is dull backache, insidious in onset</strong>, felt deep in lower lumbar or gluteal region,<strong> associated with</strong> low back <strong>morning stiffness</strong> of up to few hour duration that<strong> improves with activity</strong> and returns following period of inactivity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Question mark (?) posture&nbsp;</strong>is due to hyperkyphosis of thoracic spine and loss of lumbar lordosis.</span></li><li><span style=\"font-size:12.0pt;\">Cervical spine involvement is usually late and show forward stooping and loss of extension and rotation.</span></li><li><span style=\"font-size:12.0pt;\">Most serious complication of spinal disease is <strong>spinal fracture </strong>with even minor trauma.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Anterior uveitis</strong>: Most common (30%) extra-articular manifestation.</span></li><li><span style=\"font-size:12.0pt;\">Cataract and secondary glaucoma are common sequela.</span></li><li><span style=\"font-size:12.0pt;\">Up to 60% of patients have inflammation of colon or ileum (mostly asymptomatic, only 5-10% develop IBD), 3rd degree heart block, cardiac dysfunction (Aortic incompetence), restrictive lung disease. IgA nephropathy, prostatitis and retroperitoneal fibrosis are other manifestations and may shorten life span.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic criteria – Modified New York Criterion:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Essential criteria is definite radiographic sacroiliitis</span></li><li><span style=\"font-size:12.0pt;\"><strong>Supporting criteria: one of these 3</strong></span><ul><li><span style=\"font-size:12.0pt;\">Inflammatory back pain if 4/5 are present&nbsp;</span><ol><li><span style=\"font-size:12.0pt;\">Pain &gt; 3 months</span></li><li><span style=\"font-size:12.0pt;\">&lt; 40 years of age</span></li><li><span style=\"font-size:12.0pt;\">Insidious onset</span></li><li><span style=\"font-size:12.0pt;\">Improves with exercise</span></li><li><span style=\"font-size:12.0pt;\">Present at night</span><br>&nbsp;</li></ol></li><li><span style=\"font-size:12.0pt;\">Limited chest expansion</span></li><li><span style=\"font-size:12.0pt;\">Limited lumbar spine motion in both sagittal and frontal plane (schober test/modified schober test)</span><br>&nbsp;</li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Spine Radiograph Findings:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Haziness of sacroiliac (SI) joint margins</strong> is the earliest change.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture62_q2G5WQZ.jpg\" alt=\"\" width=\"300\" height=\"283\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sacroiliitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Later on, SI joint show irregular subchondral erosions, sclerotic articular margins, joint space widening and eventually bony ankylosis.</span></li><li><span style=\"font-size:12pt;\"><strong>Calcification of supraspinous and interspinous ligaments</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>(Dagger sign)</strong> and that of sacroiliac and sacro-tuberous ligament.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture63_61MkIzQ.jpg\" alt=\"\" width=\"250\" height=\"320\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Dagger sign (ossification along supraspinous &amp; interspinous ligaments)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Enthesopathy:</strong> Calcification at the attachment of muscles, tendons and ligaments.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Trolley/tram track sign:</strong> Three linear radiopaque lines due to ligament calcification.</span></li><li><span style=\"font-size:12.0pt;\">Squaring of vertebra, loss of lumbar lordosis and syndesmophytes are seen. Bamboo spine appearance is due to syndesmophytes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture64_sV9AOV9.jpg\" alt=\"\" width=\"400\" height=\"191\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A. Trolley track sign (ossification along supraspinous ligaments and facet joints;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>B. Bamboo spine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>MRI is the most sensitive examination for sacroiliitis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rheumatoid arthritis.&nbsp;</strong>In rheumatoid arthritis, upper cervical spine &amp; hip joint are less commonly involved. There is atlantoaxial joint subluxation when cervical spine is involved. Lumbar spine is usually spared. The chronic inflammatory synovitis in the cervical spine results in severity that progresses to bone erosion and ligamentous laxity, leading to late spinal instability. The most common radiological presentations of spinal involvement in RA are: atlantoaxial subluxation, cranial settling (also known as basilar impression, atlantoaxial impaction or superior migration of the odontoid, the most severe form of spinal instability in RA), subaxial subluxation or a combination of them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture66.jpg\" alt=\"\" width=\"300\" height=\"219\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Psoriatic arthritis.&nbsp;</strong>In the involvement of spine &amp; pelvis in psoriatic arthritis, the patient experiences extreme back/neck pain, stiffness in back/neck that improves on moving around. The stiffness worsens by a period of rest. There is difficulty in bending or moving the back. The patient also complaints of fatigue. The x-ray shows asymmetric paravertebral ossification, thicker &amp; larger syndesmophytes than ankylosing spondylitis. Occasionally, there are incomplete non-marginal syndesmophytes similar to AS.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture67.jpg\" alt=\"\" width=\"250\" height=\"455\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paget’s disease.&nbsp;</strong>It is characterized by <strong>excessive disorganized bone turnover, </strong>that encompasses excessive osteoclastic activity initially followed by disorganized excessive new bone formation. <strong>Osteoclast appears larger and irregular </strong>whereas <strong>osteoblast are relatively normal. Etiology </strong>is<strong> </strong>genetic infection by paramyxovirus (measles and respiratory syncytial virus). There is increased bone resorption accompanied by accelerated bone formation. <strong>Most people are asymptomatic. </strong>The sites most commonly involved are <strong>pelvis</strong>, tibia, followed by skull, spine, clavicle and femur. <strong>Affects men &gt; 50 years more commonly. Pain is most common presenting symptom. </strong>The spine is the second most commonly affected site (53%), after the pelvis (70%). The lumbar spine and more commonly the L4 and L5 levels are the most frequently involved sites. Involvement of the atlanto-axial region is very rare. The vertebral body is almost always involved with a portion of the neural arch. The radiological appearance is characterised by an increase in the antero-posterior and lateral vertebral dimensions. The height of the vertebra is unchanged. The vertebral end-plates are subchondral condensations of trabecular bone and do not represent true bony cortex, i.e. there is no periosteum/endosteum interface at the caudal/cranial aspect of a normal vertebra. The “early” radiographic appearance of vertebral body is thickening and hypertrophy of the trabecular bone, parallel to the end plates. Progression of the sclerotic phase in the spine leads to “ivory vertebra”, due to an increase in the density of the vertebral body.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture68.jpg\" alt=\"\" width=\"400\" height=\"331\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The described symptoms of back ache, morning stiffness and reddening of eyes, along with the bamboo spine appearance in the spine x-ray are diagnostic of ankylosing spondylitis.</span></li></ul>",
      "correct_choice_id": 87522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12825,
      "choices": [
        {
          "id": 51262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 4 only </span></span></span></p>"
        },
        {
          "id": 51263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3 and 4 </span></span></span></p>"
        },
        {
          "id": 51264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3 and 5 </span></span></span></p>"
        },
        {
          "id": 51265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 4 and 5 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A skull was recovered from a forest. According to inquest papers, woman had gone missing after a fight with her boyfriend a month back. The skull was sent to the forensic research lab. Which of the following would identify it as a female skull? (</span></span></span>INICET May 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large frontal and parietal eminence</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heavy cheek bones</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Smooth glabella</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Square orbits</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Narrow mastoid</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8785048",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439867,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. 1, 3 and 5&nbsp; </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Female Skull Characteristics:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Large frontal and parietal eminence:</span></strong><span style=\"font-size:12.0pt\"> These are more prominent in females.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Smooth glabella:</span></strong><span style=\"font-size:12.0pt\"> Females typically have a smoother glabella compared to males.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">5. Narrow mastoid:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Female mastoid processes are generally narrower and less prominent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These characteristics help in identifying the skull as female.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note - </span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">General&nbsp;</span></span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">differences between male and female bones:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">There are some general features which help to differentiate male and female bones. These are</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Size:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are larger than female bones.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Roughness:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are more rougher due to increased muscle attachment areas. Females have smooth features</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Weight:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are heavier than female bones</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Articular Surface Size:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones may have larger articular surfaces compared to females</span></span></span><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">.</span></span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Square features:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male have square features, whereas females have rounded features</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">So for individual bones, just remember the specific features, instead of general features</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Other Options</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Heavy cheek bones</span></strong><span style=\"font-size:12.0pt\">: Typical in males, as a general rule, female bones are lighter than male bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">4. </span></span></span></strong><strong><span style=\"font-size:12.0pt\">Square orbits:</span></strong><span style=\"font-size:12.0pt\"> Males have squarish features, whereas females have roundish features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most features are larger, rougher, and more prominent in male skull, except frontal eminence, parietal eminence and orbits which are more prominent or larger in females</span></span></span></p>",
      "correct_choice_id": 51264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57281,
      "choices": [
        {
          "id": 228505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">E1VNTM2</span></span></span></p>"
        },
        {
          "id": 228506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">E3VNTM2</span></span></span></p>"
        },
        {
          "id": 228507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">E2VNTM4</span></span></span></p>"
        },
        {
          "id": 228508,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E2VNTM3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 35-year-old woman is brought to the emergency department after being found unresponsive at the scene of a severe car accident. She is intubated on arrival due to poor airway protection and decreased consciousness. On examination, she opens her eyes only to painful stimuli and exhibits abnormal flexion in response to pain. Her pupils are reactive to light. The trauma team assesses her Glasgow Coma Scale (GCS) score to monitor her neurological status. Based on her clinical findings, which of the following is her most appropriate GCS score?</span></span></span></p>",
      "unique_key": "Q8470931",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439868,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: D. E2VNTM3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The Glasgow Coma Scale (GCS) score evaluates eye, verbal, and motor responses to determine the level of consciousness in patients with traumatic brain injury (TBI). In this scenario, the patient scores 2 for eye opening to pain (E2), non-testable (NT) for verbal due to intubation, and 3 for abnormal flexion (M3). Thus, the GCS score is recorded as E2VNTM3. Non-testability (NT) denotes the inability to assess the verbal component due to intubation, often seen in acute TBI cases. The GCS-P score further refines this evaluation by considering pupillary activity, enhancing prognostic accuracy. While this patient&rsquo;s GCS score focuses on eye and motor responses, her reactive pupils indicate no additional pupillary penalty in the GCS-P calculation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. E1VNTM2:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This score implies no eye opening and abnormal extension (M2), which does not match the observed painful eye opening (E2) and abnormal flexion (M3).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B. E3VNTM2:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This score incorrectly suggests eye opening to verbal command and abnormal extension posturing, which does not align with the patient&#39;s eye response to pain and abnormal flexion motor response.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. E2VNTM4:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This option overestimates the motor response as withdrawal from pain (M4), which inaccurately reflects the patient&rsquo;s actual abnormal flexion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/picture1_DIWNHwV.jpg\" style=\"height:327px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The Glasgow Coma Scale (GCS) is a widely used tool for assessing the level of consciousness in traumatic brain injury. Intubated patients are marked as non-testable (NT) for verbal response, focusing on eye and motor components. The GCS-P score further refines the assessment by incorporating pupillary activity, enhancing sensitivity and specificity in acute brain injury evaluation.</span></span></span></p>",
      "correct_choice_id": 228508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14423,
      "choices": [
        {
          "id": 57653,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleaning and dressing</span></p>"
        },
        {
          "id": 57654,
          "text": "<p><span style=\"font-size:12.0pt;\">Debridement and dressing</span></p>"
        },
        {
          "id": 57655,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleaning and skin grafting</span></p>"
        },
        {
          "id": 57656,
          "text": "<p><span style=\"font-size:12.0pt;\">Cleaning and use of allograft</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The best way to manage the wound shown in the image is: (AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-274_85LVETP.jpg\" alt=\"\" width=\"300\" height=\"210\"></span></p>",
      "unique_key": "Q6965685",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439919,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cleaning and dressing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows an abrasion. Since it is going to heal with primary intention, no grafting is required.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cleaning&nbsp;</strong>the wound involves gently removing any debris, foreign material, or contaminants from the wound site. This step helps prevent infection and promotes a healthy healing environment.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dressing&nbsp;</strong>the wound involves covering it with a sterile bandage or dressing. Dressings help maintain a moist environment, protect the wound from further contamination, and provide a barrier against external factors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In many cases, initial wound management involves cleaning the wound to prevent infection and applying a sterile dressing. This basic approach is suitable for wounds that are not deeply contaminated, do not require extensive tissue removal (debridement), and do not necessitate advanced interventions like grafting (skin graft or allograft). It provides a clean and protected environment for natural healing to occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Debridement and dressing</strong>: <strong>Debridement</strong> involves the removal of dead or contaminated tissue from the wound, which may be necessary in cases of severe infection or tissue damage. After debridement, the wound is dressed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here are some general principles for the management of a superficial abrasion:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Clean the wound: Gently clean the wound with soap and warm water to remove any dirt or debris. Use a clean cloth or sterile gauze to pat the wound dry.</span></li><li><span style=\"font-size:12.0pt;\">Apply a dressing: Cover the abrasion with a sterile dressing or adhesive bandage to keep it clean and protected. Change the dressing daily or more often if it becomes wet or dirty.</span></li><li><span style=\"font-size:12.0pt;\">Manage pain: Over-the-counter pain relievers such as acetaminophen or ibuprofen can help relieve pain and reduce inflammation.</span></li><li><span style=\"font-size:12.0pt;\">Watch for signs of infection: Keep an eye on the abrasion for signs of infection such as redness, swelling, pus, or increasing pain.</span></li><li><span style=\"font-size:12.0pt;\">Follow up: Depending on the severity of the abrasion, you may need to follow up with a healthcare provider for further evaluation and treatment.</span></li></ol>",
      "correct_choice_id": 57653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6882,
      "choices": [
        {
          "id": 27496,
          "text": "<p><span style=\"font-size:12.0pt;\">150-200 ml</span></p>"
        },
        {
          "id": 27497,
          "text": "<p><span style=\"font-size:12.0pt;\">500-600 ml</span></p>"
        },
        {
          "id": 27498,
          "text": "<p><span style=\"font-size:12.0pt;\">200-350 ml</span></p>"
        },
        {
          "id": 27499,
          "text": "<p><span style=\"font-size:12.0pt;\">350-400 ml</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are an intern and want to determine the quantity of IV fluids needed for a patient. How much amount of transient loss/insensible loss per day would you account for in your calculations? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4593828",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439921,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 500-600 ml</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some of the water losses cannot be precisely regulated. For example, there is a continuous loss of water by evaporation from the respiratory tract and diffusion through the skin, which together account for about 500-600 ml/day of water loss under normal conditions. This is termed insensible water loss because we are not consciously aware of it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When calculating the quantity of IV fluids needed for a patient, it is essential to account for approximately 500-600 ml/day of insensible water loss due to evaporation from the respiratory tract and diffusion through the skin.</span></p>",
      "correct_choice_id": 27497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9889,
      "choices": [
        {
          "id": 39522,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Activated partial thromboplastin time</span></span></span></p>"
        },
        {
          "id": 39523,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Prothrombin time</span></span></span></p>"
        },
        {
          "id": 39524,
          "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Thromboelastography</span></span></span></p>"
        },
        {
          "id": 39525,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Bleeding time</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child was brought to the emergency department with a big lesion on his forearm. As a surgery resident you decide to excise the lesion in the emergency operation theatre. Which of the following investigations will test the entire coagulation pathway? </span></span>(AIIMS NOV 2020)</p>",
      "unique_key": "Q8143543",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439922,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Thromboelastography</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Thromboelastography (TEG) tests the entire coagulation pathway. It measures coagulation cascade, platelet function, and fibrinolysis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">It is a test that quantitatively measures the ability of whole blood to form a clot. The advantages are:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Global assessment of blood coagulability, including coagulation cascade, platelet function, and fibrinolysis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Rapid real-time bedside test with a simple methodology (point-of-care testing)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Diagnosis of coagulopathic bleeding</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Guide transfusion therapy and decrease the use of blood products</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Detect dynamic changes in blood coagulation during resuscitation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Predict the clinical efficacy of therapeutic agents affecting blood coagulability</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1106.jpg\" style=\"height:348px; width:680px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1107.jpg\" style=\"height:927px; width:704px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Activated partial thromboplastin time (aPTT):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> aPTT assesses the intrinsic and common pathways of the coagulation cascade. It does not measure platelet function or fibrinolysis, so it does not test the entire coagulation pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Prothrombin time (PT):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> PT assesses the extrinsic and common pathways of the coagulation cascade. Similar to aPTT, it does not evaluate platelet function or fibrinolysis, making it less comprehensive than TEG.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Bleeding time is primarily a test of platelet function and vascular integrity. It does not assess the coagulation cascade or fibrinolysis and thus does not provide a full picture of the coagulation pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thromboelastography (TEG)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the most comprehensive test for evaluating the entire coagulation pathway, including coagulation factor activity, platelet function, and fibrinolysis, making it ideal for intraoperative and emergency settings.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Ref: <u>https://www.ncbi.nlm.nih.gov/books/NBK537061/</u></span></strong></span></span></p>",
      "correct_choice_id": 39524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6499,
      "choices": [
        {
          "id": 25965,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 25966,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿B</span></p>"
        },
        {
          "id": 25967,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Both A and B</span></p>"
        },
        {
          "id": 25968,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The graph below shows the relationship between the log(dose) and the response of three drugs, A, B, and C. Which of these drugs has the highest potency? (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/neet-pharma-1_VLHh3pD.jpg\" alt=\"\" width=\"300\" height=\"252\"></span></p>",
      "unique_key": "Q7660999",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439923,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The potency of a drug corresponds to the power of the drug. The drug which produces the response at a lower dose is more potent than another drug which produces the same response at a higher dose.</span></li><li><span style=\"font-size:12.0pt;\">The more left the curve is on the DRC, the greater is its potency.</span></li><li><span style=\"font-size:12.0pt;\">On the other hand, efficacy means the maximum response that is produced by a drug. In a DRC, the more the height of the curve, the more efficacious that drug is.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Therefore in this case,</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The potency of Drug A &gt; Drug B &gt; Drug C</span></li><li><span style=\"font-size:12.0pt;\">The Efficacy of Drug A = Drug B &gt; Drug C</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a dose-response curve, the drug with the curve furthest to the left is the most potent because it produces the desired effect at the lowest dose. In this case, Drug A is the most potent.</span></p>",
      "correct_choice_id": 25965,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6999,
      "choices": [
        {
          "id": 27964,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
        },
        {
          "id": 27965,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine</span></span></span></p>"
        },
        {
          "id": 27966,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide</span></span></span></p>"
        },
        {
          "id": 27967,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented to the casualty with signs of dehydration due to severe vomiting.<strong> </strong>The intern gave the patient a parenteral medication, following which the patient developed grimacing and abnormal posturing. What could have been the inciting drug for this reaction? (</span></span>AIIMS May 2018)</p>",
      "unique_key": "Q4673929",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439924,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Metoclopramide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoclopramide is an anti-emetic that acts by blocking the D2 receptors. It can cross the blood brain barrier and can lead to Dopaminergic blockade in the various parts of the brain leading to Acute dystonia, drowsiness, abnormal posturing, Parkinsonism etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Domperidone is also a D2 Receptor blocker, but cannot cross the BBB, therefore it does not produce such side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Atropine is an anticholinergic drug that does not typically cause extrapyramidal side effects. It is used to reduce salivation and bronchial secretions and to treat bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ranitidine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ranitidine is an H2 receptor antagonist used to reduce stomach acid production. It does not have significant central nervous system effects or cause extrapyramidal symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Domperidone</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Domperidone is also a dopamine D2 receptor blocker used as an anti-emetic. However, it does not cross the blood-brain barrier effectively and therefore does not typically cause central nervous system side effects like metoclopramide.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoclopramide, an anti-emetic that blocks D2 receptors and crosses the blood-brain barrier, can cause extrapyramidal side effects such as acute dystonia, drowsiness, abnormal posturing, and Parkinsonism-like symptoms.</span></span></span></p>",
      "correct_choice_id": 27966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24702,
      "choices": [
        {
          "id": 98769,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 98770,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        },
        {
          "id": 98771,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 98772,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 73-year-old individual arrives with painless rectal bleeding. Which of the listed investigations are conducted for this patient? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Colonoscopy</span></li><li><span style=\"font-size:12.0pt;\">CECT</span></li><li><span style=\"font-size:12.0pt;\">CEA</span></li><li><span style=\"font-size:12.0pt;\">CA 19-9</span></li></ol>",
      "unique_key": "Q7825123",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Colonoscopy:</strong> This is an endoscopic examination of the large bowel and the distal part of the small bowel. It provides a visual diagnosis and can offer biopsy or removal of suspected lesions. It is an essential diagnostic tool for any patient with per-rectal bleeding to identify potential sources such as polyps, tumors, or colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. CECT (Contrast-Enhanced Computed</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Tomography)</strong>: &nbsp;CECT can provide detailed cross-sectional images of the body. In the context of rectal bleeding, it might be used to evaluate the extent of a detected tumor, check for metastatic disease, or to view vascular anomalies that might be causing the bleeding, such as arteriovenous malformations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. CEA (Carcinoembryonic Antigen)</strong>: CEA is a tumor marker. Its level can be elevated in colorectal cancers as well as other malignancies and conditions. Monitoring the levels of CEA might help in diagnosing, prognosis, and checking the recurrence of colorectal cancers.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. CA 19-9</strong>: CA 19-9 is another tumor marker. It is more typically associated with pancreatic cancer. However, its specificity for colorectal cancer is not as high as CEA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's presenting symptom of painless rectal bleeding:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Colonoscopy is a primary diagnostic tool to visualize and biopsy any potential sources of bleeding.</span></li><li><span style=\"font-size:12.0pt;\">CECT could be useful in determining the extent of a potential tumor or to check for other causes of bleeding.</span></li><li><span style=\"font-size:12.0pt;\">CEA might be used to check for the possibility of colorectal cancer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, the investigations that would be most appropriate and relevant for this patient would be options <strong>1, 2, and 3</strong>. Therefore, answer choice D) 1, 2, and 3 is correct.</span></p>",
      "correct_choice_id": 98772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7101,
      "choices": [
        {
          "id": 28372,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drug</span></span></span></p>"
        },
        {
          "id": 28373,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adulterated drug</span></span></span></p>"
        },
        {
          "id": 28374,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unethical drug</span></span></span></p>"
        },
        {
          "id": 28375,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misbranded drug</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? (INICET MAY 2022)</span></span></p>",
      "unique_key": "Q9091530",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439926,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Misbranded drug</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#374151\">A misbranded drug refers to a drug whose labeling is inaccurate or misleading. This includes incorrect labeling of the quantity of active ingredients. In this scenario, where the medication is labeled as containing 500 mg of paracetamol but actually contains only 200 mg, it would be considered a misbranded drug.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drugs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These products are manufactured concealing the true identity of the product and made to resemble another drug, especially some popular brand, to deceive the buyer and cash on the popularity of original product. The product may or may not contain the active ingredients. Spurious drugs are usually manufactured by unlicensed anti-social elements but sometimes licensed manufacturers may also be involved.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Adulterated drugs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These are those drugs which are found to contain an adulterant/substituted product or contaminated with filth rendering it injurious to health </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.&nbsp;<span style=\"color:#374151\">Unethical drug</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#374151\">: &quot;Unethical drug&quot; is not a standard term in pharmaceutical regulation. The issue here is not primarily about ethics but rather about the accuracy of labeling and drug quality.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug labeled inaccurately with respect to its active ingredient quantity is considered a misbranded drug. Ensuring accurate labeling is crucial for regulatory compliance and consumer safety, as it ensures that drugs on the market are labeled truthfully and can be trusted for their intended use.</span></span></span></p>",
      "correct_choice_id": 28375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57282,
      "choices": [
        {
          "id": 228509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Propylthiouracil (PTU)</span></span></span></p>"
        },
        {
          "id": 228510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Carbimazole</span></span></span></p>"
        },
        {
          "id": 228511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lugol&#39;s Iodine</span></span></span></p>"
        },
        {
          "id": 228512,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive Iodine (RAI)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 30-year-old pregnant woman at 12 weeks of gestation presents to the obstetrics clinic for routine prenatal care. She has a known history of Graves&#39; disease and was started on antithyroid medication before conception. She reports compliance with her medication but is concerned about potential effects on her baby. Physical examination is unremarkable, and her thyroid function tests show slightly elevated free T4 and suppressed TSH. The patient continues her pregnancy without complications until delivery at term. At birth, the newborn is noted to have a congenital scalp defect, characterized as aplasia cutis congenita. Given the history and clinical findings, which antithyroid drug used during pregnancy is most likely responsible for this congenital abnormality?</span></span></span></p>",
      "unique_key": "Q6688666",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439927,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: B. Carbimazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Carbimazole is an antithyroid drug that is metabolized into Methimazole (MMI) in the body. Both Carbimazole and Methimazole are associated with teratogenic effects, particularly when used during the first trimester of pregnancy, due to their impact on fetal development during organogenesis. These drugs can cause congenital anomalies, including aplasia cutis congenita, a condition characterized by localized absence of skin, commonly on the scalp. To minimize these risks, Propylthiouracil (PTU) is recommended during the first trimester as it has a lower teratogenic profile. After 16 weeks of gestation, the treatment typically switches to Methimazole or Carbimazole because PTU is associated with hepatotoxicity, which is more concerning later in pregnancy. During lactation, Methimazole is preferred, and Radioactive Iodine is avoided, particularly in the early postpartum period, to prevent radiation exposure to the infant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Propylthiouracil (PTU)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">PTU is preferred during the first trimester of pregnancy due to its lower risk of teratogenicity compared to Carbimazole and Methimazole. Although it can cause hepatotoxicity, it does not lead to aplasia cutis congenita.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Lugol&#39;s Iodine</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lugol&#39;s Iodine is sometimes used to reduce thyroid hormone levels rapidly but is not commonly associated with congenital defects like aplasia cutis congenita. Its primary use is in preparation for thyroid surgery or severe hyperthyroidism, and it is not considered a first-line antithyroid drug during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Radioactive Iodine (RAI)</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Radioactive Iodine is contraindicated during pregnancy due to its destructive effects on fetal thyroid tissue. However, it is not linked to aplasia cutis congenita and is strictly avoided during pregnancy and lactation to prevent harm to the fetus and infant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole and Methimazole are associated with teratogenic effects, especially when used in the first trimester, including the risk of aplasia cutis congenita. To minimize fetal risks, Propylthiouracil (PTU) is preferred during early pregnancy, with a switch to Methimazole or Carbimazole after the first trimester due to PTU&rsquo;s potential hepatotoxicity. During lactation, Methimazole is preferred, and Radioactive Iodine is strictly avoided to protect the infant from radiation exposure through breast milk</span></span></p>",
      "correct_choice_id": 228510,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14396,
      "choices": [
        {
          "id": 57545,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcal vaccine</span></p>"
        },
        {
          "id": 57546,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid vaccine</span></p>"
        },
        {
          "id": 57547,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus influenza B vaccine</span></p>"
        },
        {
          "id": 57548,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningococcal vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vaccine is not recommended to be given before splenectomy in a 5-year-old child with hereditary spherocytosis and hypersplenism? (INICET NOV 2022)</span></p>",
      "unique_key": "Q6715326",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439978,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Typhoid vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The typhoid vaccine is typically not recommended before splenectomy in a child with hereditary spherocytosis and hypersplenism. Typhoid vaccination may lead to a transient decrease in platelet count, which can exacerbate the existing hypersplenism and increase the risk of bleeding. Therefore, it is often deferred until after splenectomy when the risk of post-vaccination thrombocytopenia is reduced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumococcal vaccine</strong>: The pneumococcal vaccine is recommended for individuals with asplenia (absence of the spleen) or hyposplenism (reduced spleen function) because they are at an increased risk of severe infections, including those caused by Streptococcus pneumoniae. However, for individuals with hereditary spherocytosis who have an intact spleen, the pneumococcal vaccine may be administered as part of routine immunization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Haemophilus influenza B vaccine</strong>: The Haemophilus influenzae type B (Hib) vaccine is recommended as part of routine childhood immunization and does not have specific contraindications related to hereditary spherocytosis or splenectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Meningococcal vaccine</strong>: The meningococcal vaccine is recommended for individuals with asplenia or hyposplenism, as they are at an increased risk of meningococcal infections. However, for individuals with hereditary spherocytosis who have an intact spleen, the meningococcal vaccine may be administered as part of routine immunization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Typhoid vaccine is often deferred in children with hereditary spherocytosis and hypersplenism before splenectomy due to the risk of transiently reduced platelet count, which can be problematic in the presence of hypersplenism. Other vaccines, such as the pneumococcal, Haemophilus influenzae B, and meningococcal vaccines, may be administered based on routine immunization recommendations and the individual's spleen status.</span></p>",
      "correct_choice_id": 57546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7073,
      "choices": [
        {
          "id": 28260,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OCD</span></span></span></p>"
        },
        {
          "id": 28261,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dementia</span></span></span></p>"
        },
        {
          "id": 28262,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PTSD</span></span></span></p>"
        },
        {
          "id": 28263,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bipolar disorder</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an off-label use of risperidone? (</span></span>INICET May 2021)</p>",
      "unique_key": "Q1129055",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439979,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Bipolar disorder</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Off-label drug use refers to the prescription of a medication for a condition that is not included in its approved labeling by the Food and Drug Administration (FDA). </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Risperidone is FDA-approved for the treatment of bipolar disorder. It is specifically approved for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder, both as monotherapy and as an adjunct to lithium or valproate.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Other Options:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>A.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>OCD (Obsessive-Compulsive Disorder)</strong>: The use of risperidone for OCD is generally considered off-label. While antipsychotics like risperidone can be used adjunctively in treatment-resistant OCD, it&#39;s not an FDA-approved indication.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>B.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>Dementia</strong>: Using risperidone for the treatment of behavioral symptoms in dementia is off-label. Although it&#39;s sometimes prescribed for this purpose, it&#39;s important to note that the FDA has issued a black box warning about the increased risk of death when using antipsychotic drugs in elderly patients with dementia-related psychosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>C.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>PTSD: (Post-Traumatic Stress Disorder)</strong>: The use of risperidone in PTSD is also off-label. It has been studied and used for managing certain symptoms of PTSD, but it is not an FDA-approved indication for this condition.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Educational Objective:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risperidone is FDA-approved for the treatment of bipolar disorder, making it a labeled use. In contrast, the use of risperidone for OCD, dementia, and PTSD are off-label indications.</span></span></span></p>",
      "correct_choice_id": 28263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14088,
      "choices": [
        {
          "id": 56313,
          "text": "<p><span style=\"font-size:12.0pt;\">Liposarcoma</span></p>"
        },
        {
          "id": 56314,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
        },
        {
          "id": 56315,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial sarcoma</span></p>"
        },
        {
          "id": 56316,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibroma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most frequently observed tumor in the retroperitoneal space? (AIIMS NOV 2020)</span></p>",
      "unique_key": "Q9364667",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439980,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Liposarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Liposarcoma is the most commonly observed tumor in the retroperitoneal space. Liposarcomas are malignant tumors that arise from adipocytes and are most frequently located in the retroperitoneum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rhabdomyosarcoma</strong>: Rhabdomyosarcoma is a malignant tumor of muscle origin. While it can occur in various parts of the body, it is more commonly associated with pediatric populations in the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Synovial sarcoma</strong>: Synovial sarcoma is a rare type of cancer that tends to arise near large joints but can occur anywhere in the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neurofibroma</strong>: Neurofibromas are benign peripheral nerve sheath tumors. While they can occur in various parts of the body, including the retroperitoneum, they are not the most frequently observed tumor in this location. It's also important to note that when associated with certain genetic conditions like Neurofibromatosis type 1, they can be seen in multiple areas of the body, but they still don't surpass liposarcomas in frequency in the retroperitoneal space.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Retroperitoneal tumors can be benign or malignant and may be of various origins.</span></li><li><span style=\"font-size:12.0pt;\">Mesodermal tumors are the most common malignant retroperitoneal tumors.</span></li><li><span style=\"font-size:12.0pt;\">The order of frequency for primary retroperitoneal malignancy is liposarcoma, leiomyosarcoma, rhabdomyosarcoma, fibrosarcoma, and malignant nerve sheath tumors.</span></li><li><span style=\"font-size:12.0pt;\">Liposarcoma has three histologic varieties, which are well-differentiated and undifferentiated liposarcoma, pleomorphic liposarcoma, and myxoid/round cell liposarcoma.</span></li><li><span style=\"font-size:12.0pt;\">Among the three subtypes, pleomorphic liposarcoma is the most malignant and often metastasizes, while well-differentiated liposarcoma is the least malignant.</span></li></ul>",
      "correct_choice_id": 56313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24417,
      "choices": [
        {
          "id": 97629,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in intrathoracic pressure adding to left ventricular pressure</span></p>"
        },
        {
          "id": 97630,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in intrathoracic pressure adding to aortic pressure</span></p>"
        },
        {
          "id": 97631,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in left atrial pressure</span></p>"
        },
        {
          "id": 97632,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in left ventricular volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The rise in blood pressure that occurs at the onset of the Valsalva maneuver is a result of?&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/08/whatsapp-image-2023-07-04-at-125616.jpg\" alt=\"\" width=\"300\" height=\"297\"></span></p>",
      "unique_key": "Q4973909",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Increase in intrathoracic pressure adding to aortic pressure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Valsalva maneuver</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">can lead to a temporary increase in blood pressure due to its effects on the cardiovascular system. This phenomenon can be explained by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased Intrathoracic Pressure:</strong> By trying to exhale against a closed airway, you create increased pressure within your chest cavity. This can compress the large blood vessels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased Sympathetic Activity:</strong> The increased intrathoracic pressure</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">triggers the body’s sympathetic nervous system, which is responsible for the</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">“fight or flight” response. This leads to the release of stress hormones like adrenaline and norepinephrine. These hormones cause blood vessels to constrict (vasoconstriction), which further raises blood pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increase in intrathoracic pressure adding to left ventricular pressure:&nbsp;</strong>Incorrect. The pressure increase primarily affects the aorta and systemic circulation, not just the left ventricular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase in left atrial pressure</strong>: Incorrect. While there may be a slight increase in left atrial pressure, it is not the primary cause of the rise in blood pressure observed during the Valsalva maneuver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increase in left ventricular volume:&nbsp;</strong>Incorrect. The maneuver does not directly increase left ventricular volume; instead, it increases pressure within the thoracic cavity affecting the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:12.0pt;\">The rise in blood pressure at the onset of the Valsalva maneuver is primarily due to the increase in intrathoracic pressure adding to aortic pressure, along with increased sympathetic activity.</span></p>",
      "correct_choice_id": 97630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10085,
      "choices": [
        {
          "id": 40306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cadherins</span></span></span></p>"
        },
        {
          "id": 40307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Platelet endothelial cell adhesion molecule-1 (PECAM-1)</span></span></span></p>"
        },
        {
          "id": 40308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E-selectin</span></span></span></p>"
        },
        {
          "id": 40309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cd11a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following molecules are involved in helping the leukocytes to roll over the endothelial cells in the vessels?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>",
      "unique_key": "Q1986356",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439982,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) E-selectin</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E-selectins are involved in rolling of leucocytes over endothelial cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cellular Changes during Inflammation</span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-153326.jpg\" style=\"height:637px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture16.jpg\" style=\"height:218px; width:700px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cadherins:</span></strong><span style=\"font-size:12.0pt\"> These are involved in cell-cell adhesion in various tissues but are not specifically involved in the rolling of leukocytes during inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. PECAM-1 (Platelet endothelial cell adhesion molecule-1):</span></strong><span style=\"font-size:12.0pt\"> PECAM-1 is primarily involved in the process of diapedesis, where leukocytes transmigrate across the endothelium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. CD11a:</span></strong><span style=\"font-size:12.0pt\"> This is an integrin (part of the LFA-1 complex) involved in the firm adhesion of leukocytes to the endothelium, not in the rolling process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">E-selectin is critical for the rolling of leukocytes along the endothelial cells during the early stages of the inflammatory response.</span></span></span></p>",
      "correct_choice_id": 40308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57283,
      "choices": [
        {
          "id": 228513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Dexamethasone</span></span></span></p>"
        },
        {
          "id": 228514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Ciprofloxacin</span></span></span></p>"
        },
        {
          "id": 228515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 228516,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous Immunoglobulin (IVIG)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 21-year-old man with a recent diagnosis of acute promyelocytic leukemia (APML) has been undergoing treatment with arsenic trioxide and all-trans retinoic acid. After one week of therapy, he presents to the emergency department with high fever, shortness of breath, and new bilateral infiltrates on his chest X-ray. His physical examination reveals tachypnea and mild hypoxia. What is the next best step in management?</span></span></span></p>",
      "unique_key": "Q4612624",
      "question_audio": null,
      "question_video": null,
      "map_id": 12439983,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Correct Answer: A) Dexamethasone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">This patient&rsquo;s presentation is highly suggestive of differentiation syndrome, a serious complication associated with the treatment of acute promyelocytic leukemia (APML) with arsenic trioxide and all-trans retinoic acid. Differentiation syndrome is characterized by fever, respiratory distress, pulmonary infiltrates, and pleural effusions that develop during the initial weeks of therapy. The first-line treatment is high-dose corticosteroids, specifically dexamethasone, which helps reduce inflammation and prevent progression of the syndrome. Prompt recognition and early administration of dexamethasone can significantly improve outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option B) Ciprofloxacin:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> While ciprofloxacin is an antibiotic used for bacterial infections, it is not effective in treating differentiation syndrome. This syndrome is inflammatory rather than infectious, so antibiotics are not beneficial unless a secondary bacterial infection is confirmed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C) Amphotericin B:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Amphotericin B is an antifungal medication typically used for invasive fungal infections. Although immunocompromised patients like those with leukemia may be at risk for fungal infections, the clinical features of differentiation syndrome do not align with those of a fungal etiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D) Intravenous Immunoglobulin (IVIG):</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> IVIG is used in various conditions, including autoimmune disorders and certain immunodeficiencies. However, it has no role in managing differentiation syndrome, which primarily requires anti-inflammatory therapy rather than immune modulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Differentiation syndrome is a potentially life-threatening complication of acute promyelocytic leukemia treatment with arsenic trioxide and all-trans retinoic acid. It presents with fever, respiratory distress, and pulmonary infiltrates, and is effectively treated with high-dose corticosteroids like dexamethasone. Prompt recognition and initiation of corticosteroids are essential for reducing morbidity and preventing progression.</span></span></span></p>",
      "correct_choice_id": 228513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31890,
      "choices": [
        {
          "id": 127430,
          "text": "<p><span style=\"font-size:12.0pt;\">High Ki67+</span></p>"
        },
        {
          "id": 127431,
          "text": "<p><span style=\"font-size:12.0pt;\">ER+</span></p>"
        },
        {
          "id": 127432,
          "text": "<p><span style=\"font-size:12.0pt;\">BRCA 1 +</span></p>"
        },
        {
          "id": 127433,
          "text": "<p><span style=\"font-size:12.0pt;\">P53 +</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a good prognostic factor for breast cancer patients? (NEET PG 2023)</span></p>",
      "unique_key": "Q5062908",
      "question_audio": null,
      "question_video": null,
      "map_id": 12440034,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) ER+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ER+ is a good prognostic factor for breast cancer patients as it is seen with luminal A and B subtypes of the breast cancer.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. High Ki67+:&nbsp;</strong>High Ki67+ indicates a high proliferative index, which is associated with more aggressive tumors and a poorer prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. BRCA1+:&nbsp;</strong>BRCA1 mutation is associated with an increased risk of developing breast and ovarian cancers, and these cancers tend to be more aggressive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. P53+:&nbsp;</strong>P53 mutations are associated with a variety of cancers and typically indicate a poorer prognosis due to the loss of normal p53 tumor suppressor function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ER-positive status in breast cancer is a good prognostic factor because it indicates a slower-growing tumor that is likely to respond well to hormone therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Why ER⁺ is a Good Prognostic Factor:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Slower tumor growth:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">ER⁺ tumors tend to grow more slowly than ER⁻ tumors.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Better treatment response:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">ER⁺ cancers respond well to hormonal therapies such as:</span></li><li><span style=\"font-size:12.0pt;\">Tamoxifen</span></li><li><span style=\"font-size:12.0pt;\">Aromatase inhibitors</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Lower recurrence risk:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hormone receptor–positive cancers have a lower risk of early recurrence.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Overall survival:</span><ul><li><span style=\"font-size:12.0pt;\">Patients with ER⁺ tumors generally have better overall survival.</span></li></ul></li></ol>",
      "correct_choice_id": 127431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13743,
      "choices": [
        {
          "id": 54933,
          "text": "<p><span style=\"font-size:12.0pt;\">Gallbladder and inferior vena cava</span></p>"
        },
        {
          "id": 54934,
          "text": "<p><span style=\"font-size:12.0pt;\">Porta hepatis and inferior vena cava</span></p>"
        },
        {
          "id": 54935,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate lobe and quadrangular lobe</span></p>"
        },
        {
          "id": 54936,
          "text": "<p><span style=\"font-size:12.0pt;\">Right and left lobe of liver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The cholecysto-vena caval line is an anatomical landmark that connects which of the following structures? </span>(NEET PG 2019)</p>",
      "unique_key": "Q1265543",
      "question_audio": null,
      "question_video": null,
      "map_id": 12560976,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A.&nbsp;Gallbladder and inferior vena cava</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The cholecysto-vena caval line (Cantlie line) considered as true mid line of liver.</span></li><li><span style=\"font-size:12.0pt;\">The Cantlie line is a fictitious line that divides the liver into two parts.</span></li><li><span style=\"font-size:12.0pt;\">It contains the middle hepatic vein and extends from the midpoint of the gallbladder fossa at the inferior margin of the liver to the midpoint of the groove for inferior vena cava (IC).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-917.jpg\" alt=\"\" width=\"500\" height=\"382\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anatomy on visceral surface of the liver with division into right and left lobes by the plane of Rex-Cantlie line.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Porta Hepatis and Inferior Vena Cava</strong>: The porta hepatis, often called the \"hilum of the liver,\" is a deep fissure on the inferior surface of the liver where several key structures, including the portal vein, common hepatic duct, and hepatic artery, enter or leave the liver. Though the porta hepatis is an essential landmark in liver anatomy and surgery, it's not associated with the cholecysto-vena caval line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Caudate Lobe and Quadrangular Lobe</strong>: There isn't a distinct \"quadrangular lobe\" in the human liver. The liver has main lobes named right, left, caudate, and quadrate lobes. The caudate and quadrate lobes are smaller lobes situated on the liver's inferior surface. While they have importance in liver anatomy, they don't define the cholecysto-vena caval line.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Right and Left Lobe of Liver</strong>: On the Diaphragamatic surface Tthe human liver is typically divided into a larger right lobe and a smaller left lobe by the falciform ligament (anteriorly). The cholecysto-vena caval line helps delineate the boundary between the right and left lobes when viewed posteriorly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cholecysto-vena caval line is an imaginary line drawn from the fundus of the gallbladder to the point where the inferior vena cava (IVC) pierces the diaphragm. It roughly demarcates the boundary between the right and left lobes of the liver, especially when viewed from behind (posterior view).</span></p>",
      "correct_choice_id": 54933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2838,
      "choices": [
        {
          "id": 11337,
          "text": "<p><span style=\"font-size:12.0pt;\">Real time PCR</span></p>"
        },
        {
          "id": 11338,
          "text": "<p><span style=\"font-size:12.0pt;\">Conventional PCR with Restriction Fragment Length pair technique</span></p>"
        },
        {
          "id": 11339,
          "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR</span></p>"
        },
        {
          "id": 11340,
          "text": "<p><span style=\"font-size:12.0pt;\">RT-PCR followed by Real time PCR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is more appropriate for quantitative analysis of viral RNA genome?(INICET NOV 2021)</span></p>",
      "unique_key": "Q6422748",
      "question_audio": null,
      "question_video": null,
      "map_id": 12560977,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) RTPCR followed by Real time PCR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">RT-PCR followed by Real time PCR</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">To quantitatively analyze viral RNA genomes, two key processes are required:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Reverse Transcription (RT): Viral RNA must first be converted into complementary DNA (cDNA) because PCR (Polymerase Chain Reaction) can only amplify DNA. This is done using Reverse Transcriptase, hence RT-PCR (Reverse Transcription PCR).</span></li><li><span style=\"font-size:16px;\">Quantification using Real Time PCR (qPCR): Once the cDNA is synthesized, Real-Time PCR is used to quantify the amount of target nucleic acid in real time using fluorescent markers.</span></li></ol><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Thus, for quantitative analysis of viral RNA:</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><ul><li><span style=\"font-size:16px;\"><strong>First step → RT-PCR</strong></span></li><li><span style=\"font-size:16px;\"><strong>Second step → Real-Time PCR (qPCR)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Real Time PCR: </strong>This refers to quantification but only works with DNA, not directly with RNA. Without the reverse transcription step, it cannot quantify viral RNA.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option B. Conventional PCR with RFLP: </strong>This is qualitative and used for genotyping or mutation detection, not quantitative analysis.</span><br><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong>Option C. RT-PCR: </strong>RT-PCR alone allows detection of RNA (qualitative), but not quantification unless combined with Real-Time PCR.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">RT PCR followed by Real-time PCR is the most appropriate technique for quantitative analysis of viral RNA genomes, allowing real-time monitoring and quantification of&nbsp;viral&nbsp;RNA&nbsp;load.</span></p>",
      "correct_choice_id": 11340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 452,
      "choices": [
        {
          "id": 1804,
          "text": "<p><span style=\"font-size:12.0pt;\">Right lobe of liver</span></p>"
        },
        {
          "id": 1805,
          "text": "<p><span style=\"font-size:12.0pt;\">Quadrate lobe of liver</span></p>"
        },
        {
          "id": 1806,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate lobe of liver</span></p>"
        },
        {
          "id": 1807,
          "text": "<p><span style=\"font-size:12.0pt;\">Fundus of gallbladder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old woman was undergoing cholecystectomy. During the procedure, the resident accidentally advanced the scissors along the superior border of the epiploic foramen causing injury. Which of the following structures is likely to be injured?(AIIMS NOV 2017)</span></p>",
      "unique_key": "Q1552581",
      "question_audio": null,
      "question_video": null,
      "map_id": 12678425,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Caudate lobe of liver</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The caudate lobe is a small, distinct lobe of the liver that lies posterior to the porta hepatis and forms the posterior border of the lesser omentum. Importantly, it forms the <strong>superior border</strong> of the epiploic foramen. Thus, during</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">cholecystectomy, an injury advancing the scissors along the superior border of the epiploic foramen could damage the caudate lobe.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epiploic foramen is a vertical slit of about 3 cm behind the free right border of the lesser omentum. It connects the lesser sac to the greater sac.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-15.jpg\" alt=\"\" width=\"400\" height=\"293\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical note:</strong> Pringle maneuver (as shown below) is a technique where the free margin of the lesser omentum is compressed to obtain rapid control of bleeding from the hepatic artery and portal vein in liver trauma and surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-16.jpg\" alt=\"\" width=\"400\" height=\"423\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Right lobe of liver</strong>: The right lobe of the liver is a major lobe, and it constitutes the majority of the liver's mass. It does not directly border the epiploic foramen. The anterior surface of the right lobe faces the anterior abdominal wall, and the posterior surface is related to the diaphragm and right kidney.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Quadrate lobe of liver</strong>: The quadrate lobe is a smaller lobe situated on the visceral surface of the liver. It is bounded by the gallbladder on the right and the round ligament of the liver on the left. It is separated from the left lobe by the fissure for the ligamentum teres. While it's close to the region, the quadrate lobe does not form the superior border of the epiploic foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Fundus of gallbladder</strong>: The fundus is the most distal part of the gallbladder and it usually projects beyond the inferior border of the liver, contacting the anterior abdominal wall. It is not directly related to the epiploic foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Boundaries of epiploic foramen</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-14-123943.png\" alt=\"\" width=\"700\" height=\"528\"></p>",
      "correct_choice_id": 1806,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}